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This first chapter explains the main topic of the thesis, oropharyngeal dysphagia, and 
the aspects related to its assessment. The chapter presents the research questions 
addressed in the thesis and briefly introduces the contents of each chapter.
Deglutition
Swallowing, or rather deglutition, is a highly organized sequence of movements and 
sensory processes that involves fine coordination regulated by both cortical and 
brainstem processes.[1, 2] Figure 1 shows the various anatomical structures that are 
involved in swallowing: the lips(1), teeth(2), oral cavity(3), tongue(4), palate(5), 
pharynx(6), epiglottis(7), larynx(8), esophagus(9), and vocal folds(10).[2] Muscle 
innervation and sensory feedback are provided by the cranial nerves V, VII, IX, X, XI, 
and XII.[2, 3]
Swallowing occurs in four phases, starting with the oral preparatory phase (Figure 2A). 
This phase consists of voluntary actions required before a swallowing reflex is initiated, 
e.g. mastication and bolus placement. The second is the oral phase (Figure 2B), 
comprising the oral transport of the bolus to the pharynx, which is the last voluntary 
act before the swallowing reflex is initiated. The third is the pharyngeal phase (Figure 
2C). In this phase, the bolus is transported through the pharynx, the larynx is elevated, 
the vocal folds are closed, and the tongue and the pharyngeal muscles transport the 
bolus towards the esophagus. In the fourth and last phase, the esophageal phase 
Figure 1. Anatomical structures involved in swallowing.
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INTRODUCTION
(Figure 2D), the bolus enters the esophagus and is transported towards the stomach 
by peristaltic movements.[2, 4]
Swallowing disorders (dysphagia)
The concept of oropharyngeal dysphagia (OD) captures the arduous disruption of the 
process of transporting solids or liquids from the mouth to the esophagus.[5] This 
concept includes penetration into the larynx or aspiration of the bolus below the vocal 
fold level into the trachea[6]. OD can also take the form of oropharyngeal residue or 
pooling after swallowing.[7] It is associated with malnutrition, dehydration, aspiration 
Figure 2A. Oral preparatory phase.
Figure 2C. Pharyngeal phase.
Figure 2B. Oral phase.
Figure 2D. Esophageal phase.
2001816 binnenwerk_Bastiaan Heijnen.indd   11 20-08-18   08:58
CHAPTER 1
12
pneumonia, and sudden death. [8-11] Dysphagia is also known to have severe negative 
impacts on the quality of life. [12, 13]. 
Prevalence and patient populations
OD is often secondary to iatrogenic, metabolic, myopathic, neurogenic, or structural 
conditions. The most common causes are neurological, due to stroke or 
neurodegenerative diseases; the second most common ones are iatrogenic, resulting 
from surgery or radiation. [7] The prevalence of OD, as reported in the literature, varies 
from 2 to 16% in a normal population, and older age is associated with higher 
prevalence.[14] The prevalence of OD varies by medical condition: a prevalence of 
8-80% was found after stroke, of 11-81% in Parkinson’s disease, and of 27-30% after 
head trauma.[15]
Screening for dysphagia
The aim of screening for dysphagia is to identify at-risk patients. According to the 
World Health Organization a screening tool is a simple test to identify a subject with 
a disease or complaint but without the symptoms. [16] The screening methods should 
be easy to administer and quick, avoiding burden and invasiveness for the patients.
[17] An important feature of a screening tool is that it strikes the right balance 
between sensitivity and specificity. Sensitivity refers to the proportion of positive-
tested subjects who actually have the disease. Specificity is the opposite, referring 
to the proportion of negative-tested subjects in whom the disease is absent. A 
sensitivity of 70% and a specificity of 60% is considered a minimal requirement for 
an OD screening tool. [18]
In everyday medical practice a clinician often starts to investigate the presence of 
dysphagia by asking the patient whether there are swallowing complaints.[19] In 
addition, patients can be subjected to a (bedside) dysphagia screening, of which there 
are several types. Clinical features of aspiration can be noted with or without using 
a standardized form to determine whether a patient is at risk for dysphagia. Also a 
trial swallow using water or a substance in different viscosities can be combined with 
testing oxygen desaturation to detect patients at risk for OD.[17, 18, 20] Examples 
of evidence-based screening methods are the 3-oz. water swallow test[21], a V-VST 
(volume-viscosity swallowing test)[22, 23], a TOR-BSST (Toronto Bedside Swallowing 
Screening Test)[23], and a cough test[24]. A positive result indicates that further 
assessment for dysphagia is needed. To illustrate, consider the procedure of  the 
3-oz. water swallow test. A patient is instructed to drink a glass of water (90 cc) all at 
once. Meanwhile, the patient is observed for signs of aspiration; those may take the 
form of coughing, choking, clearing the throat, watery eyes, or shortness of breath. 
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When the subject undergoing screening test scores positive on one of the signs, 
further assessment for dysphagia is needed. 
Assessment for dysphagia
After failing the initial screening, the patient should undergo further dysphagia 
assessment.[17] The two gold standards are fiberoptic endoscopic evaluation of 
swallowing (FEES) and videofluoroscopy (VFS). The latter is a radiographic examination 
of the swallowing act, which allows the investigator to visualize the complete trajectory 
of the swallowing act from mouth to stomach. VFS may show abnormal structures, 
pathological muscle activity, penetration, aspiration, and passage problems (Figure 
3A). A disadvantage of VFS is the X-ray load for the patient.[2] The other gold standard, 
FEES, is the observation of swallowing in real time with a flexible nasendoscope 
introduced via the nose into the pharynx. By showing the swallowing act in motion, 
FEES gives information about the occurrence of penetration, aspiration, or passage 
problems (Figure 3B). In contrast to VFS, however, it only shows the swallowing act in 
the pharyngeal phase, not after passing through the upper esophageal sphincter and 
below. Another disadvantage derives from the short interval during swallowing in which 
there is a white-out due to muscle contractions.[25]
Patient-perceived aspects of dysphagia
Functional Health Status (FHS) is the ability to perform tasks in multiple domains [26] 
and it serves as an indicator of the influence of a given disease on particular functional 
Figure 3A. VFS shows aspiration of thin liquids.
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aspects of a person. In dysphagia, FHS assessment quantifies the severity of the 
symptoms. This measure is complemented by Health-Related Quality of Life (HRQoL), 
which refers to the unique perception individuals may have of their health, taking into 
account social, functional, and psychological issues.[26] HRQoL can be divided into 
generic HRQoL and disease-specific HRQoL. The latter evaluates HRQoL in patients 
with a specific diagnosis and takes the characteristics and conditions of a disease into 
account. It has to be sensitive to measure the effects of a condition or intervention.
[27] Generic HRQoL is able to measure a wide variety of characteristics, including clinical 
and sociodemographic features.
The severity that the consequences of dysphagia may have on different aspects of a 
patient’s life, as measured in terms of either FHS or HRQoL, is usually ascertained from 
patient self-report questionnaires. Before a questionnaire can be used in everyday 
clinical practice or for research purposes, however, its measurement properties (its 
reliability, validity, and responsiveness) should be evaluated and be judged sufficient.
[28, 29] These aspects are, among other characteristics, described in psychometrics.
Psychometrics
Psychometrics refers to the construction and validation of measurement instruments.
[30] The main domains for checking whether a questionnaire is a reliable and valid 
form of measurement, as determined by the COSMIN taxonomy of measurement 
Figure 3B. FEES shows residue after swallowing with penetration of blue-dyed thick liquids. The residue creates 
the risk of aspiration. 
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properties and definitions for health-related patient-reported outcomes (HR-PRO), are 
reliability, validity, and responsiveness.[28] Reliability is the degree to which a measure 
is free from measurement error. Validity is the degree to which an HR-PRO instrument 
measures the construct it purports to measure. Responsiveness is the ability of an 
HR-PRO instrument to detect change over time in the construct to be measured.[28] 
Only measures or questionnaires with psychometric properties that are deemed 
sufficient should be used to evaluate a patient’s status or treatment outcome.
Treatment of dysphagia
When the assessments show significant abnormalities, treatment is indicated. There 
are six categories of treatment modalities for OD.[31] The first is bolus modification 
and management, which includes adjusting the viscosity, volume, temperature, and/
or acidity of the bolus. The second comprises behavioral techniques such as oral motor 
exercises. The third is sensory and neurophysiologic stimulation, for example taste or 
temperature adaptation or electrical stimulation. The fourth is postural adjustment, 
e.g. chin-tuck or head-turn maneuvers. The fifth consists of swallow maneuvers such 
as effortful swallow or Mendelsohn maneuver, the latter referring to prolonging the 
larynx in a high position to prevent aspiration. And the last is adjunctive biofeedback, 
which gives a patient visual information on the swallowing act.[2, 31-33]  
AIM AND SCOPE
The aim of this thesis is to improve the measurement and evaluation of OD, focusing 
on the use of patient self-report measures. 
The first study, presented in chapter 2, investigates the effects of radiochemotherapy 
on dysphagia, voice, speech, and trismus in patients with head and neck cancer (HNC). 
HNC patients suffer from various functional, physical, and emotional impairments due 
to both the primary illness and the secondary consequences of the tumor treatment 
[34]. Head and neck oncological treatments can have a severe impact on the anatomical 
structures, organ function, and quality of life [35]. 
A systematic review was conducted to study the effects of radiotherapy or chemotherapy 
on functions of the upper aerodigestive tract, including swallowing, in HNC patients. 
Data on patient characteristics, interventions, outcome measures, and treatment 
effects were summarized. Furthermore, the available evidence on interventions by 
speech pathologists was examined.
In chapter three, therapy effects are compared to determine the effects of traditional 
therapy and neuromuscular electrical stimulation (NMES) on patient self-reported 
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HRQoL in patients with Parkinson’s disease and OD. NMES may be a therapeutic 
adjunct to known interventions in the treatment of OD [36-38]. The rationale 
underpinning NMES is that stimulation of muscle fibers by stimulating the nerve and 
the motor end plate would result in a re-education of the functional muscle-contraction 
patterns[38, 39]. 
In a randomized controlled trial the effects of adjunctive NMES in dysphagic Parkinson’s 
disease patients were compared to traditional speech language therapy for dysphagia 
treatment with HRQoL as the primary outcome measure. It was hypothesized that 
NMES would not only lead to significant improvement of the swallowing function but 
would also contribute to an increased HRQoL in these patients. 
Chapter 4 makes a comparison between daily clinical practice and the use of screening 
tools. It determines the diagnostic performance of daily clinical practice versus patient 
self-report tools in patients with OD. In daily clinical practice, a single question such as 
‘What about swallowing?’ is frequently used without any additional standardized testing. 
The purpose of this study was to compare the diagnostic performance of a single 
question on swallowing with the FHS questionnaire EAT-10[40] as reference test. It was 
hypothesized that a single question, ‘What about swallowing?’, would show poor 
diagnostic performance when compared to the EAT-10. It was expected that the single 
question would have insufficient sensitivity and specificity to identify patients at risk 
of dysphagia.
In chapter 5 the reliability and validity of common self-report measures in OD are 
determined. Quality of life is considered to be an important patient-reported outcome 
measure in objectifying the current health status or therapy effects in patients with 
OD. In this study, the validity and reliability of the Dutch version of the Deglutition 
Handicap Index (DHI) and the MD Anderson Dysphagia Inventory (MDADI) were 
determined in oncological patients with OD. 
Chapter 6 explores the predictive value of self-report measures for aspiration. The 
presence of aspiration is the most critical clinical sign of OD. Screening for and detecting 
OD may be done in several ways, but the gold standard is FEES or VFS. Unfortunately, 
the gold standard is often not available when dysphagia has to be assessed. The 
purpose of this study was to build a model to forecast aspiration in patients with OD 
using common patient self-evaluation questionnaires and oral intake status. Logistic 
regression was used to build a model to predict aspiration. Performance of the model 
was evaluated by constructing receiver operating characteristic (ROC) curves and 
computing the area under the curve (AUC). 
Chapter 7 provides a general summary and draws some conclusions. On that basis, a 
number of recommendations for future research are made. 




1. Miller, A., Deglutition. phys. rev, 1982(62): p. 129-184.
2. Logemann, J., Evaluation and Treatment of Swallowing Disorders. 1984.
3. Shaker R., B.P., Postma G., Easterling C.,, Principles of Deglutition: A Multidisciplinary Text for Swallowing and 
its Disorders. 2012: Springer Science & Business Media.
4. Ekberg, O., Dysphagia, Diagnosis and Treatment. 2017: Springer.
5. Verin, E., et al., Oropharyngeal dysphagia: when swallowing disorders meet respiratory diseases. Eur Respir J, 
2017. 49(4).
6. Rosenbek, J.C., et al., A penetration-aspiration scale. Dysphagia, 1996. 11(2): p. 93-8.
7. Cook, I.J. and P.J. Kahrilas, AGA technical review on management of oropharyngeal dysphagia. Gastroenterology, 
1999. 116(2): p. 455-78.
8. Kirshner, H.S., Causes of neurogenic dysphagia. Dysphagia, 1989. 3(4): p. 184-188.
9. Mari, F., et al., Predictive value of clinical indices in detecting aspiration in patients with neurological disorders. 
Journal of Neurology, Neurosurgery &amp; Psychiatry, 1997. 63(4): p. 456-460.
10. Martin, L., et al., Effect of electrical stimulation training on the contractile characteristics of the triceps surae 
muscle. European Journal of Applied Physiology and Occupational Physiology, 1993. 67(5): p. 457-461.
11. McHorney, C.A., et al., The SWAL-QOL and SWAL-CARE outcomes tool for oropharyngeal dysphagia in adults: 
III. Documentation of reliability and validity. Dysphagia, 2002. 17(2): p. 97-114.
12. Gustafsson, B. and L. Tibbling, Dysphagia, an unrecognized handicap. Dysphagia, 1991. 6(4): p. 193-199.
13. Plowman-Prine, E.K., et al., The relationship between quality of life and swallowing in Parkinson’s disease. 
Movement Disorders, 2009. 24(9): p. 1352-1358.
14. Kertscher, B., et al., Prevalence of oropharyngeal dysphagia in the Netherlands: a telephone survey. Dysphagia, 
2015. 30(2): p. 114-20.
15. Takizawa, C., et al., A Systematic Review of the Prevalence of Oropharyngeal Dysphagia in Stroke, Parkinson’s 
Disease, Alzheimer’s Disease, Head Injury, and Pneumonia. Dysphagia, 2016. 31(3): p. 434-441.
16. World Health Organization. Early detection of cancer. 2017; Available from: http://www.who.int/cancer/
detection/en/.
17. Speyer, R., Oropharyngeal dysphagia: screening and assessment. Otolaryngol Clin North Am, 2013. 46(6): p. 
989-1008.
18. Kertscher, B., et al., Bedside screening to detect oropharyngeal dysphagia in patients with neurological disorders: 
an updated systematic review. Dysphagia, 2014. 29(2): p. 204-12.
19. Heijnen, B.J., et al., ‘What about swallowing?’ Diagnostic performance of daily clinical practice compared with 
the Eating Assessment Tool-10. Dysphagia, 2015. 32: p. 214-22.
20. Bours, G.J., et al., Bedside screening tests vs. videofluoroscopy or fibreoptic endoscopic evaluation of swallowing 
to detect dysphagia in patients with neurological disorders: systematic review. J Adv Nurs, 2009. 65(3): p. 477-93.
21. Suiter, D.M., S.B. Leder, and D.E. Karas, The 3-ounce (90-cc) water swallow challenge: a screening test for 
children with suspected oropharyngeal dysphagia. Otolaryngol Head Neck Surg, 2009. 140(2): p. 187-90.
2001816 binnenwerk_Bastiaan Heijnen.indd   17 20-08-18   08:59
CHAPTER 1
18
22. Clave, P., et al., Accuracy of the volume-viscosity swallow test for clinical screening of oropharyngeal dysphagia 
and aspiration. Clin Nutr., 2008. 27: p. 806-15.
23. Martino R, S.F., Teasell R, Bayley M, Nicholson G, Streiner DL, Diamant NE., The Toronto Bedside Swallowing 
Screening Test (TOR-BSST): development and validation of a dysphagia screening tool for patients with stroke. 
Stroke, 2009. 40: p. 555-61.
24. Wakasugi Y, T.H., Hattori F, Motohashi Y, Nakane A, Goto S, Ouchi Y, Mikushi S, Takeuchi S, Uematsu H. , 
Screening test for silent aspiration at the bedside. Dysphagia, 2008. 23: p. 364-70.
25. Baijens, L.W., et al., FEES protocol derived estimates of sensitivity: aspiration in dysphagic patients. Dysphagia, 
2014. 29(5): p. 583-90.
26. Ferrans, C.E., et al., Conceptual model of health-related quality of life. J Nurs Scholarsh, 2005. 37(4): p. 336-42.
27. Briançon, S., et al., Disease-Specific Versus Generic Measurement of Health-Related Quality of Life in Cross-
Sectional and Longitudinal Studies: an Inpatient Investigation of the SF-36 and Four Disease-Specific Instruments, 
in Statistical Methods for Quality of Life Studies: Design, Measurements and Analysis, M. Mesbah, B.F. Cole, 
and M.-L.T. Lee, Editors. 2002, Springer US: Boston, MA. p. 87-99.
28. Mokkink, L.B., et al., The COSMIN checklist for assessing the methodological quality of studies on measurement 
properties of health status measurement instruments: an international Delphi study. Qual Life Res, 2010. 19(4): 
p. 539-49.
29. Speyer, R., et al., Psychometric properties of questionnaires on functional health status in oropharyngeal 
dysphagia: a systematic literature review. Biomed Res Int, 2014: p. 458678.
30. Ginty, A.T., Psychometric Properties, in Encyclopedia of Behavioral Medicine, M.D. Gellman and J.R. Turner, 
Editors. 2013, Springer New York: New York, NY. p. 1563-1564.
31. Speyer, R., Behavioral Treatment of Oropharyngeal Dysphagia. Med Radiol Diagn Imaging, 2017.
32. Newman, R., et al., Effect of Bolus Viscosity on the Safety and Efficacy of Swallowing and the Kinematics of the 
Swallow Response in Patients with Oropharyngeal Dysphagia: White Paper by the European Society for Swallowing 
Disorders (ESSD). Dysphagia, 2016. 31(2): p. 232-49.
33. Speyer, R., et al., Effects of therapy in oropharyngeal dysphagia by speech and language therapists: a systematic 
review. Dysphagia, 2010. 25(1): p. 40-65.
34. Kreeft, A.M., et al., Speech and swallowing after surgical treatment of advanced oral and oropharyngeal 
carcinoma: a systematic review of the literature. Eur Arch Otorhinolaryngol, 2009. 266(11): p. 1687-1698.
35. Rogers, S.N., S.A. Ahad, and A.P. Murphy, A structured review and theme analysis of papers published on 
‘quality of life’ in head and neck cancer: 2000–2005. Oral Oncology, 2007. 43(9): p. 843-868.
36. Bogaardt, H., et al., Use of Neuromuscular Electrostimulation in the Treatment of Dysphagia in Patients with 
Multiple Sclerosis. Annals of Otology, Rhinology &amp; Laryngology, 2009. 118(4): p. 241-246.
37. Bulow, M., et al., Neuromuscular Electrical Stimulation (NMES) in Stroke Patients with Oral and Pharyngeal 
Dysfunction. Dysphagia, 2008. 23(3): p. 302-309.
38. Freed ML, F.L., Chatburn RL, Christian M. , Electrical stimulation for swallowing disorders caused by stroke. 
Respir. Care, 2001. 46: p. 466-474.
39. Freed ML, W.Y., VitalStim Certification Program. Training manual for patient assessment and treatment using 
VitalStim electrical stimulation. 2003, Hixson TN: Chattanooga Group.
40. Belafsky, P.C., et al., Validity and reliability of the Eating Assessment Tool (EAT-10). Ann Otol Rhinol Laryngol, 
2008. 117(12): p. 919-24.
2001816 binnenwerk_Bastiaan Heijnen.indd   18 20-08-18   08:59
19
 
2001816 binnenwerk_Bastiaan Heijnen.indd   19 20-08-18   08:59
2
2001816 binnenwerk_Bastiaan Heijnen.indd   20 20-08-18   08:59
1  Dept. of Otorhinolaryngology and Head and Neck Surgery, Leiden University Medical Centre, Leiden,  
The Netherlands.
2  School of Public Health, Tropical Medicine and Rehabilitation Sciences, James Cook University, Townsville, 
QLD, Australia.
3 Kantonsspital Winterthur, Winterthur, Switzerland.
4 School of Occupational Therapy and Social Work, Curtin University, Perth, WA, Australia. 
5  Dept. of Family Medicine, School of Health Professions Education (SHE), Maastricht University Medical 
Centre, Maastricht, The Netherlands.
6 Speech Pathology Service, Gold Coast Health, Brisbane, QLD, Australia. 
7  Discipline of Speech Pathology, Faculty of Health Sciences, The University of Sydney, Sydney, NSW,  
Australia.
Published in: Biomed Res Int. 2016;2016:6086894.
BJ Heijnen1, R Speyer2,1, B Kertscher3, R Cordier4,2, KWJ Koetsenruijter5, K Swan6,
HCA Bogaardt7
Dysphagia, speech, 
voice and trismus 
following radiotherapy 
and/or chemotherapy 
in patients with head 
and neck carcinoma:  
a review of literature





Patients with head and neck cancer suffer from various impairments due to the primary 
illness, as well as secondary consequences of the oncological treatment. This systematic 
review describes the effects of radiotherapy and/or chemotherapy on the functions of 
the upper aerodigestive tract in patients with head and neck cancer.
Methods
A systematic literature search was performed by two independent reviewers using the 
electronic databases PubMed and Embase. All dates up to May 2016 were included. 
Results
Of the 947 abstracts, sixty articles met the inclusion criteria and described one or more 
aspects of the sequelae of radiotherapy and/or chemotherapy. Forty studies described 
swallowing-related problems, 24 described voice-related problems, seven described 
trismus and 25 studies described general quality of life. Only 14 articles reported that 
speech pathologists conducted the interventions, of which only six articles described 
in detail what the interventions involved.
Conclusion
In general, voice quality improved following intervention, whereas quality of life, 
dysphagia and oral intake deteriorated during and after treatment. However, as a 
consequence of the diversity in treatment protocols and patient characteristics, the 
conclusions of most studies cannot be easily generalised. Further research on the 
effects of oncological interventions on the upper aerodigestive tract is needed.
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FUNCTIONAL OUTCOMES AFTER (C)RT
INTRODUCTION
Head and neck oncological patients suffer from various functional, physical, and 
emotional impairments due to both the primary illness and the secondary consequences 
of the tumor treatment [1]. The oncological treatment of head and neck tumors 
depends on the location and the stage of the tumor, as well as the treatment 
preferences of the individual patient. Head and neck oncological treatment can include 
surgery, radiotherapy, chemotherapy or combinations of these. The impact of head 
and neck oncological treatments on the anatomical structures, organ function and the 
quality of life (QoL) should not be underestimated [2]. For instance, the implications 
of loss of function for people treated non-surgically for head and neck cancer (HNC) 
and its detrimental effects on functioning and QoL are well documented [3].
In order to assist people with dysphagia to adjust to, and live successfully with the 
sequelae of the primary condition, speech pathologists managing this caseload need 
to ensure post-treatment services are available [4] that address not only the physical 
but also the emotional and psychosocial needs. A qualitative study by Nund et al. [5] 
exploring dysphagia management by speech pathologists suggests that care givers 
generally feel ill-prepared for their role. Furthermore, this study suggests that clinicians 
should provide adequate and timely training and support to carers. Furthermore, 
Krisciunas et al. [6] concluded that within speech pathology there is no standardised 
therapy for HNC patients and scant evidence to support any particular protocol. As a 
result, institutions and individual speech pathologists need to develop their own 
protocols based on ‘standard’ practices or anecdotal evidence.
Evidence-based practice (EBP) is hailed to be paramount in the practice of speech 
pathology [7]. The American Speech-Language-Hearing Association (ASHA) defines 
evidence-based practice as, “...an approach in which current, high-quality research 
evidence is integrated with practitioner expertise and client preferences and values, 
into the process of making clinical decisions” [8]. Essentially, EBP involves moving the 
foundation for clinical decisions from clinical protocols centered solely on expert 
opinion to the integration of clinical expertise, the best current research evidence, and 
individual client values. To facilitate EBP in healthcare, clinical practice guidelines can 
be developed to summarise clinically relevant evidence [9].
Several reviews have been published about the outcomes after radiotherapy and/or 
chemotherapy in HNC patients (e.g., Frowen et al. [10]; Jacobi et al. [11]; van der Molen 
et al. [12]; Paleri et al. [13]; Roe et al. [14]). Most of the reviews focused on selected 
functional domains in populations with HNC: health-related QoL [15], swallowing [13, 
14, 16], and voice and speech [11]. Only the review by van der Molen et al. [12] covered 
a wider range of functional outcomes in patients with advanced HNC, including 
2001816 binnenwerk_Bastiaan Heijnen.indd   23 20-08-18   08:59
CHAPTER 2
24
swallowing, mouth opening, nutrition, pain and QoL. Further, the purpose of some 
studies was to provide evidence-based clinical guidelines (e.g., Paleri et al. [13]) and 
did not perform systematic literature searches in line with the PRISMA guidelines [17]. 
As such, even though a number of reviews have been published over the last ten years, 
a comprehensive updated systematic review is needed that includes all functional 
domains affected by radiotherapy and/or chemotherapy in patients with head and 
neck carcinoma.
A systematic review was conducted to describe the effects of radiotherapy and/or 
chemotherapy on functions of the upper aerodigestive tract in patients with HNC and 
examined the evidence of interventions by speech pathologists.
METHODS
A systematic literature search was performed by two independent reviewers. The 
electronic biomedical databases PubMed and Embase were used (search period from 
start of database until 5 May 2016). The searches were limited to English language 
publications. In Pubmed the MeSH terms larynx or hypopharynx were combined with 
all MeSH terms related to head and neck neoplasms (Table 1). Next, the results were 
linked to all MeSH terms for chemotherapy or radiotherapy, after which the outcome 
was combined with all MeSH terms found for dysfunctions of the upper aerodigestive 
tract and limited with adults +19 years. The exact syntax of the literature search is 
presented in Table 1.
In Embase the thesaurus terms larynx or hypopharynx were linked to neoplasm and 
radiotherapy or chemotherapy. Next, the search outcome was combined with the 
following terms: dysphagia, speech, speech disorder, voice, dysphonia, xerostomia, quality 
of life, dysarthria or trismus (see Table 1). 
To identify the most recent publications, the search was complemented by free-text 
words in PubMed and Embase (for the period after April 2015 until May 2016). 
Truncation symbols and wildcards were used to search for variant forms of words or 
word extensions. Laryn*, pharyn* or hypopharyn* were combined with cancer*, 
neoplasm*, tumour* or carcinoma*. Furthermore, these free text words were combined 
with radiation*, radiotherap*, chemotherap*, adjuvant therap* or radiochemotherap* 
and, finally, combined with deglut*, swallow*, dysphag*, speech*, voic*, articulat*, 
dysphon*, quality of life*, xerostom*, dysarthr* or anarthr*. 
Only articles presenting both pre- and post-intervention data of the upper aerodigestive 
tract functions of the participants were included. Review articles and studies with a 
population sample of less than 20 patients were excluded, as well as experiments on 
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Table 1. Search strategies per literature database




Embase: (larynx/ OR pharynx/ OR hypopharynx/) AND (neoplasm/ OR 
larynx disorder/ OR pharynx disorder/ OR larynx cancer/ OR larynx 
carcinoma/ OR pharynx cancer/ OR pharynx carcinoma/)
AND (radiotherapy/ OR chemotherapy/ OR chemoradiotherapy/ OR 
adjuvant therapy/  OR drug therapy/)
AND (speech sound disorder OR speech/ or speech disorder/ OR 
swallowing/ OR dysphagia/ OR dysphonia/ OR voice disorder/ OR 
aphonia/ OR speech intelligibility/ OR xerostomia/ OR dysarthria/ OR 
esophagus speech/ OR larynx prosthesis/ OR trismus/ OR “quality of 
life”/)
English 201
PubMed: (“Larynx”[Mesh] OR “Pharynx”[Mesh] OR “Hypopharynx”[Mesh]) 
AND (“Neoplasms”[Mesh] OR “Head and Neck Neoplasms”[Mesh] OR 
“Neoplasms, Second Primary”[Mesh] OR  “Pharyngeal Neoplasms”[Mesh] 
OR “Oropharyngeal Neoplasms”[Mesh] OR “Tonsillar Neoplasms”[Mesh] 
OR “Nasopharyngeal Neoplasms”[Mesh] OR “Mouth Neoplasms”[Mesh] 
OR “Laryngeal Neoplasms”[Mesh] OR “Tongue Neoplasms”[Mesh] OR 
“Thyroid Neoplasms”[Mesh] OR “Salivary Gland Neoplasms”[Mesh] OR 
“Jaw Neoplasms”[Mesh] OR “Lip Neoplasms”[Mesh] OR “Thyroid 
Carcinoma, Anaplastic”[Mesh] OR  “Neoplasms, Squamous Cell”[Mesh] 
OR “Neoplasms, Basal Cell”[Mesh] OR “Otorhinolaryngologic 
Neoplasms”[Mesh] OR “Hypopharyngeal Neoplasms”[Mesh] OR 
“Laryngeal Diseases”[Mesh] OR “Pharyngeal Diseases”[Mesh]) AND 
(“Radiotherapy”[Mesh] OR “Radiotherapy, Adjuvant”[Mesh] OR 
“Radiotherapy, High-Energy”[Mesh] OR “Radiotherapy, Image-
Guided”[Mesh] OR “Radiotherapy, Intensity-Modulated”[Mesh] OR 
“Radiotherapy, Conformal”[Mesh] OR “Radiotherapy, Computer-
Assisted”[Mesh] OR “Radiotherapy Planning, Computer-Assisted”[Mesh] 
OR “Radiotherapy Dosage”[Mesh] OR “Brachytherapy”[Mesh] OR 
“Radiosurgery”[Mesh] OR “Radiation Oncology”[Mesh] OR “Dose-
Response Relationship, Radiation”[Mesh] OR “Consolidation 
Chemotherapy”[Mesh] OR “Induction Chemotherapy”[Mesh] OR 
“Maintenance Chemotherapy”[Mesh] OR “Chemotherapy, 
Adjuvant”[Mesh] OR “Chemotherapy, Cancer, Regional Perfusion”[Mesh] 
OR “Drug Therapy”[Mesh] OR “Drug Therapy, Combination”[Mesh] OR 
“Radiotherapy”[Mesh] OR “Radiation Dosage”[Mesh]) AND (“Articulation 
Disorders”[Mesh] OR “Speech”[Mesh] OR “Speech Sound 
Disorder”[Mesh] OR “Speech, Esophageal”[Mesh] OR “Speech, 
Alaryngeal”[Mesh] OR “Speech Intelligibility”[Mesh] OR “Speech 
Disorders”[Mesh] OR “Deglutition Disorders”[Mesh] OR 
“Deglutition”[Mesh] OR “Dysphonia” [Mesh] or “Voice Disorders” [Mesh] 
or “Hoarseness” [Mesh] or “Aphonia” [Mesh] OR “Xerostomia”[Mesh] 
OR “Dysarthria”[Mesh] OR “Larynx, Artificial”[Mesh] OR “Speech, 





Free Text Embase: (larynx* or pharynx* OR hypopharyn* OR laryngo* OR 
larynge*) AND (cancer OR cancers OR neoplasm* OR tumour* OR tumor 
OR tumors OR carcinoma*) AND (radiation* OR radiotherap* OR 
chemotherap* OR adjuvant therap* OR radiochemotherap*) AND 
(deglut* OR swallow* OR dysphag* OR speech* OR voic* OR hoarse* 
OR aphon* OR rough* OR articulat* OR dysphon* OR (quality AND life) 
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animals or articles not published in English. Furthermore, studies published before 
1990, case reports, expert opinions, and articles describing combinations of therapy 
including surgical interventions were excluded. 
Final decisions on inclusion were made based on the original articles by consensus 
between two expert reviewers in accordance with the PRISMA statement [17]. The 
reference lists of all the included articles were searched for additional literature. Next, 
the standard quality assessment QualSyst as described by Kmet et al. [18] was 
performed in order to evaluate the methodological strength and weaknesses of the 
included studies. All ratings were performed by two independent reviewers. After 
consensus, studies with poor methodology scores (<50%) were excluded. All included 
articles were classified according to the Australian National Health and Medical 
Research Council (NHMRC) Evidence Hierarchy [19]. Data were retrieved from all studies 
and tabulated; further details on selected speech pathology interventions were 
summarised separately.
RESULTS
Using MeSH or thesaurus terms, 304 articles were located in PubMed and 201 in 
Embase. Free-text word searches resulted in another 148 articles in PubMed and 397 
in Embase. The combination of these searches, without overlap, yielded 947 articles. 
Figure 1 outlines the PRISMA reviewing process according to Moher et al. [20]. Sixty 
articles met all inclusion criteria.
Table 2 shows the outcomes of the QualSyst critical appraisal tool by Kmet et al. [18]. 
As all studies had sufficient methodological quality, no further studies were excluded; 
the overall methodological quality ranged from adequate to good with 0 studies ranked 
as poor, 3 studies as adequate, 3 studies as good, and 54 studies as strong. Based on 
the NHMRC Evidence Hierarchy [19], 6 studies were classified as level II evidence and 
54 studies as level III evidence.
All 60 studies focussed on different functions of the upper aerodigestive tract following 
radiotherapy and/or chemotherapy for HNC. The following constructs were evaluated 
across the different studies: communication (voice and speech), functions of the 
digestive tract (oral intake, weight loss, dysphagia, trismus, xerostomia and tube 
dependency), QoL and overall survival rates.
Table 3 provides a summary of the 60 retrieved observational and intervention studies 
that met the inclusion criteria. The first column presents the reference of the author(s). 
The second column represents the number of subjects, the third column the etiology 
of the head and neck malignancies and the 4th column displays the staging of the 
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malignancies. The 5th column shows whether voice and/or speech, digestive tract and 
QoL were studied. The 6th and 7th columns show the evaluation techniques and the 
treatment, respectively. The 8th column present the follow-up and the last column 
describes the author’s key findings.
Voice and/or speech function
Twenty-four studies evaluated voice and/or speech function [21-43] with a follow-up 
time ranging from 1 month follow-up [42] to ten years follow-up [43]. Most studies 
included patients with laryngeal tumors only, however 11 studies [22, 25, 30, 31, 34-38, 
Figure 1. PRISMA Flow chart
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44] also included non-laryngeal tumors. Seventeen studies [21, 23, 24, 26, 28, 29, 31-33, 
35, 36, 38-43] included patients with low-grade tumors (i.e., T1, T2), 15 studies included 
patient with advanced tumors [22, 23, 25, 27, 30-38, 42, 44].
Table 2. Methodological quality based on QualSyst critical appraisal tool by Kmet et al. 2004 [18] and NHMRC 
1999 [19] evidence level of included articles
Reference Kmet score (%) Methodological 
Quality1
NHMRC level of 
evidence2
Aaltonen et al. 2014 [24] 25 / 28 (89%) Strong II
Ackerstaff et al. 2009 [25] 22 / 28 (79%) Good II
Agarwal et al. 2009 [26] 19 / 24 (79%) Good III-2
Agarwal et al. 2011 [45] 17 / 20 (85%) Strong III-3
Akst et al. 2004 [46] 17 / 20 (85%) Strong III-3
Al-Mamgani et al. 2012 [27] 19 / 20 (95%) Strong III-3
Al-Mamgani et al. 2012 [47] 21 / 22 (95%) Strong III-3
Al-Mamgani et al. 2013 [28] 21 / 22 (95%) Strong III-3
Al-Mamgani et al. 2015 [29] 21 / 22 (95%) Strong III-3
Arraras Urdaniz et al. 2005 [77] 18 / 20 (90%) Strong III-2
Bansal et al. 2004 [30] 14 / 24 (58%) Adequate III-3
Bibby et al. 2008 [21] 18 / 22 (82%) Strong III-2
Bottomley et al. 2013 [78] 24 / 28 (86%) Strong II
Buchbinder et al. 1993 [48] 14 / 26 (54%) Adequate III-1
Caudell et al. 2010 [49] 21 / 22 (95%) Strong III-3
Christianen et al. 2015 [50] 21 / 22 (95%) Strong III-3
Cohen et al. 2006 [74] 19 / 20 (95%) Strong III-3
Dornfeld et al. 2007 [22] 17 / 22 (77%) Strong III-3
Dijkstra et al. 2007 [51] 19 / 22 (86%) Strong III-3
Feng et al. 2007 [52] 19 / 22 (86%) Strong III-3
Feng et al. 2010 [53] 20 / 20 (100%) Strong III-3
Frowen et al. 2009 [16] 22 / 22 (100%) Strong III-2
Haderlein et al. 2013 [54] 17 / 20 (85%) Strong III-3
Hutcheson et al. 2014 [55] 18 / 20 (90%) Strong III-3
Jacobi et al. 2016 [31] 17 / 18 (94%) Strong III-3
Karlsson et al. 2015 [32] 26 / 28 (93%) Strong II
Karlsson et al. 2016 [33] 18 / 20 (90%) Strong III-3
Kazi et al. 2008 [34] 17 / 20 (85%) Strong III-2
Kerr et al. 2015 [35] 19 / 20 (95%) Strong III-2
Kotz et al. 2012 [56] 24 / 28 (86%) Strong II
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Reference Kmet score (%) Methodological 
Quality1
NHMRC level of 
evidence2
Kraaijenga et al. 2015 [36] 19 / 20 (95%) Strong III-3
Kumar et al. 2014 [57] 19 / 20 (95%) Strong III-2
Lazarus et al. 2014 [38] 19 / 20 (95%) Strong III-3
List et al. 1999 [75] 15 / 18 (83%) Strong III-3
McLaughlin et al. 2009 [58] 19 / 20 (95%) Strong III-3
Mittal et al. 2001 [37] 16 / 20 (80%) Strong III-3
Murry et al. 1998 [59] 11 / 20 (55%) Adequate III-3
Niedzielska et al. 2010 [39] 17 / 20 (85%) Strong III-2
Nourissat et al. 2010 [60] 23 / 26 (88%) Strong III-3
Ottoson et al. 2014 [61] 19 / 22 (86%) Strong III-3
Pauli et al. 2012 [62] 19 / 22 (86%) Strong III-3
Pauloski et al. 2006 [63] 18 / 20 (90%) Strong III-3
Rademaker et al. 2003 [64] 17 / 20 (85%) Strong III-3
Remmelts et al. 2013 [40] 18 / 20 (90%) Strong III-3
Salama et al. 2008 [65] 17 / 20 (85%) Strong III-3
Sanguineti et al. 2014 [23] 19 / 20 (95%) Strong III-3
Scrimger et al. 2007 [66] 18 / 20 (90%) Strong III-3
Spector et al. 1999 [41] 17 / 22 (77%) Good III-3
Starmer et al. 2014 [67] 18 / 20 (90%) Strong III-3
Stenson et al. 2009 [68] 16 / 20 (80%) Strong III-3
Strigari et al. 2010 [69] 17 / 20 (85%) Strong III-3
Tuomi et al. 2015 [42] 18 / 20 (90%) Strong III-2
Vanshtein et al. 2015 [70] 20 / 24 (83%) Strong III-3
van der Molen  et al. 2010 [76] 24 / 26 (92%) Strong II
van der Molen et al. 2012 [44] 16 / 20 (80%) Strong III-3
van der Molen et al. 2013 [71] 19 / 20 (95%) Strong III-3
Verdonck-de Leeuw et al. 1999 [43] 18 / 20 (90%) Strong III-2
Verdonck-de Leeuw et al. 2014 [79] 16 / 20 (80%) Strong III-2
Vlacich et al. 2014 [72] 18 / 20 (90%) Strong III-3
Wilson et al. 2011 [73] 18 / 20 (90%) Strong III-3
1 Methodological quality: strong >80%; good 60 – 79%; adequate 50 – 59; poor <50.
2 NHMRC Evidence Hierarchy designates the following hierarchy: Level I (evidence obtained from a systematic 
review of all relevant RCTs), level II (evidence obtained from at least one properly designed RCT), level III-1 
(evidence obtained from well-designed pseudo-RCTs [alternate allocation or some other method]), level III-2 
(evidence obtained from comparative studies with concurrent controls and allocation not randomised [cohort 
studies], case control studies, or interrupted time series with a control group), level III-3 (evidence obtained 
from comparative studies with historical control, two or more single-arm studies, or interrupted time series 
without a parallel control group), and level IV (evidence obtained from case series, either post-test or pre-test 
and post-test).
Table 2. Continued
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Nine studies [21, 26, 31, 33, 34, 36, 39, 42, 44] used acoustic analysis to evaluate voice 
quality, six studies [27-29, 35, 36, 40] used the Voice Handicap Index and three studies 
[24, 39, 43] used videolaryngostroboscopy. In several studies, either descriptions of 
how voice quality was evaluated were missing or non-validated tools were used (e.g., 
patients self-reporting or trial-specific questionnaires). Only four studies [23, 26, 32, 
44] reported whether the patient received any voice therapy.
All the studies reported good to excellent outcomes for voice quality at long term 
follow-up. Some studies specifically reported pre- to post-treatment improvements of 
voice or speech quality following radiotherapy and/or chemotherapy [21, 25, 26]. 
However, other studies [23, 38, 42, 44] reported a deterioration after therapy at long 
term follow-up. Al-Mamgani et al. [29] found a better voice outcome in case of single 
vocal cord irradiation compared with irradiation of the whole larynx. Mittal et al. [37] 
concluded that radiation with tissue/dose compensation (TDC) improved articulatory 
outcome compared to radiation without TDC. 
Functions of the digestive tract
Forty studies [16, 22, 25, 35-38, 42, 45-76] describe the effects of radiotherapy and/or 
chemotherapy on the functions of the digestive tract and used a variety of outcome 
measures. Of these 40 studies, 16 studies [16, 36, 37, 45, 49, 52, 53, 55, 57, 61, 63, 65, 
67, 68, 71, 76] used videofluoroscopy to measure physiological changes in swallowing 
function. Eight studies [22, 36, 46, 47, 49, 54, 58, 72] used feeding tube dependency as 
a (dichotomous) outcome, whereas seven studies [36, 46, 56, 63, 64, 67, 76] described 
the level of oral intake in more detail. Only four studies [36, 38, 55, 73] used a condition 
specific validated measure for swallowing disorders (e.g. MDADI). 
With regard to nutritional status, five studies [22, 58, 60, 61, 76] used the body mass 
index as an outcome or reported specifically on weight gain or loss. Seven studies [36, 
38, 48, 51, 62, 71, 76] used the presence of trismus as an outcome by reporting on the 
maximum distance of mouth opening. Saliva flow (as a measure of xerostomia) was 
used in four studies [37, 38, 66, 69].
Follow-up times in these studies range from immediately post-therapy [60] to 6 years 
post-therapy [36], describing both low stage tumors and more advanced tumors. Thirty-
two studies used the TNM-classification system, stage was described in six other studies 
and the remaining two studies did not report on tumor stage or grade. However, it 
was unclear whether the clinical TNM-score or the pathological TNM-score was used 
to describe the severity of the disease. Eight studies [16, 36, 46, 48, 51, 55, 56, 67, 71, 
76] described whether the patients received functional treatment (by a speech 
pathologist); the remainder of the articles did not mention whether the patient received 
any additional treatment.
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Nine studies reported impaired swallowing function following radiotherapy and/or 
chemotherapy [38, 45, 50, 53-55, 67, 72, 73].
Five studies [16, 59, 64, 74, 75] showed that swallowing was least affected at baseline, 
worst immediately following post-treatment (0-3 months post-treatment), and 
improved by 6-12 months post-treatment and later. However, swallowing usually did 
not return to pre-treatment functioning level. In four studies [49, 52, 57, 71], a relation 
between dose-volume, dysphagia and aspiration was found. Caudell et al. [49] showed 
that a mean radiation dosage >41 Gy with >24% volume of the larynx being radiated, 
was associated with increased percutaneous endoscopic gastrostomy (PEG) dependency 
and aspiration. Akst et al. [46] correlated advanced tumor stage and age >60 years 
with a deterioration of swallowing.
Ackerstaff et al. [25] demonstrated improved oral intake post-radiotherapy and/or 
chemotherapy. Stenson et al. [68] stated that weight remained unchanged after 
treatment (via oral route), whereas Nourissat et al. [60] described a mean weight loss 
of 2.2 kg post-treatment.
QoL
Twenty-five studies [21, 22, 25, 27, 28, 30, 32, 33, 36, 38, 42, 44, 47, 52, 54, 60, 62, 66, 
70, 73-75, 77-79] described the short- and long-term effects of treatment for HNC on 
patients’ general QoL. The European Organization for Research and Treatment of 
Cancer (EORTC) C30-questionnaire was used in fifteen studies [25, 27, 28, 30, 32, 33, 
36, 42, 47, 54, 60, 62, 77-79] and the more HNC specific EORTC H&N35 was used in 
thirteen studies [25, 27, 28, 32, 33, 36, 38, 42, 47, 62, 77-79]. Other questionnaires that 
were used included the University of Washington QoL Questionnaire (UWQoL) [52, 66, 
70, 73], the Head and Neck QoL or HNQoL [52, 70] and the Xerostomia Related QoL or 
XQoL [66, 70]. Follow-up time for QoL was up to six years post-treatment [36], including 
patients with tumors that were early staged and patients with advanced tumors. 
Although three studies [21, 70, 77] demonstrated improvements in QoL, four studies 
[25, 38, 42, 53] reported a decrease in general QoL as a result of radiotherapy and/or 
chemotherapy. Bansal et al. [30] found a significant decline in physical, social and 
emotional functioning as well as in global health scores following a course of 
radiotherapy. However, the patients’ functional scores improved one month post-
treatment, but did not reach pre-treatment levels. The health-related QoL (HRQoL) 
scores of the majority of patients in the Bottomley et al. [78] study returned to baseline 
at 48 months follow-up. These findings support the findings of Ackerstaff et al. [25], 
Cohen et al. [74], Karlsson et al. [33], List et al. [75] and Wilson et al. [73], who suggested 
that HRQoL deteriorates significantly immediately post-treatment, with variable 
degrees of improvement 3-72 months post-treatment.
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Reported (efficacy of) speech pathology interventions
We assessed the speech pathology interventions against the following criteria: a) 
whether a detailed description of the intervention was provided; b) whether the authors 
provided a description of treatment duration and intensity; and c) what the speech 
pathology intervention outcomes were. The reported efficacy of 14 speech pathology 
intervention studies aimed at addressing problems in dysphagia, speech, voice and 
trismus are summarised in Table 4. 
Of the 60 articles included in this review, 14 studies [16, 22, 23, 26, 32, 36, 44, 46, 48, 
55, 56, 67, 71, 76] reported whether there was any treatment for the sequelae of 
radiotherapy and/or chemotherapy. Of these intervention studies, five focused on 
voice-related problems [23, 26, 32, 36, 44], two focused on trismus [48, 51], seven 
focused on swallowing disorders [16, 36, 46, 55, 56, 67, 76] and one study reported on 
both swallowing disorders and trismus [71].
The three studies that investigated the treatment of trismus [48, 51, 71] presented the 
most detailed information on what the interventions involved. The study by Dijkstra 
et al. [51] described a wide variety of trismus-specific therapies, suggesting that most 
patients received a combination of therapies. The patients in the Van der Molen et al. 
[44] and Kraaijenga et al. [36] studies did not receive any speech therapy. The remainder 
of the studies reported that patients received speech therapy; however, most of these 
studies did not provide specific data on treatment duration or intensity. None of the 
voice-related studies provided information on the specific exercises prescribed to 
patients except Karlsson et al [32]. 
Of the eight studies on swallowing disorders, only Kotz et al. [56] and van der Molen 
et al. [76] described the prescribed exercises in detail. The aim of the latter study was 
to compare the effectiveness of experimental rehabilitation to standard rehabilitation 
in 49 advanced HNC patients. The authors concluded that preventive rehabilitation is 
feasible and effective in reducing the extent and/or severity of various functional short-
term effects of chemoradiotherapy [71]. This finding is supported by the 6 years follow-
up study by Kraaijenga et al. [36]. Kotz et al. [56] described a temporary improvement. 
These are the only studies that provided detailed information about the speech 
pathology intervention and reported on the effectiveness of the intervention.
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In total, 60 studies met the inclusion criteria. The studies described the effects of 
radiotherapy and/or chemotherapy on the functions of the upper aerodigestive tract 
in patients with HNC. The articles yielded by this systematic review vary in their findings 
regarding tumor characteristics and treatment modalities. As a result of this variability, 
no statistical pooling was possible. We also set out to investigate the involvement of 
speech pathologists in treating patients with HNC.
When considering treatment outcomes, voice quality worsened at the start of 
radiotherapy and/or chemotherapy, but eventually improved after therapy finished. 
Dysphagia can be a major side-effect of HNC and its treatment. The high incidence of 
dysphagia in this study population can cause serious secondary consequences, such 
as: malnutrition, dehydration, an increased risk of aspiration and, at worst, death [80]. 
As dysphagia is a common sequelae to oncological treatment, early detection and 
treatment is needed to avoid, or minimise serious secondary complications [81]. 
The general description of the study population in Table 3 shows that there was great 
variability in both the location of the tumor, and the grading/staging, making 
comparisons of these studies difficult. As the follow-up times varied in each study, the 
outcomes may be non-comparable. Thus, this review shows that there is a need for a 
more standardised approaches to research in this field.
Additionally, a large range of outcome measures were used - some of which are not 
validated. This calls into question the reliability of results reported in some of the 
studies. The use of validated and standardised assessments in future research would 
provide more robust findings.
When considering the functional outcomes of radiotherapy and/or chemotherapy, one 
of the most important factors is whether the patient had received voice or swallowing 
therapy. Interestingly, only 14 of the 60 included studies reported whether the patients 
received any speech therapy. Thus, in 46 articles functional results, such as voice 
quality, are presented with no specification of whether the patient received therapy. 
As some of these studies have a follow-up of >2 years, it is fair to assume that patients 
sought help for voice or swallowing problems. Therefore, the involvement of speech 
therapy may be underreported, suggesting that the presented outcomes in these 
studies are biased and raise questions about their reliability.
When information was provided about treatment, only six articles [32, 48, 51, 56, 71, 
76] described in detail both the treatment intensity as the actual treatment. 
Furthermore, these studies are the only five that include conclusions about the efficacy 
of speech therapy in this specific population. In the context of EBP, this finding 
demonstrates the need for more research into the efficacy of speech pathology 
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interventions for patients with HNC receiving radiotherapy and/or chemotherapy.
To enable the objective reporting of the effectiveness of radiation and/or chemotherapy, 
baseline measurements of different aspects of voice quality and swallowing are 
required. To manage expectations, health care professionals and patients need to be 
made aware that some aspects of both voice and swallowing commonly do not recover 
to the level prior to the oncological intervention [16]. Regarding effectiveness of voice 
treatments, the following multidimensional assessment is recommended [82]: a 
videolaryngostroboscopy recording of the laryngeal structures and the vocal fold 
vibration; an acoustic and a perceptual analysis of voice; a voice-related questionnaire 
on QoL (e.g., the Voice Handicap Index) [83], and a functional health status 
questionnaire. Such a protocol would be in line with the recommendations for 
functional assessment of voice pathology as described by the Committee on Phoniatrics 
of the European Laryngological Society [84]. 
When describing aspects of swallowing function, both fiberoptic endoscopic evaluation 
of swallowing and videofluoroscopy are considered to be the gold standard in 
dysphagia assessment [85]. In addition to these tools, questionnaires on HRQoL and 
functional health status are recommended and should be integrated in the overall 
swallowing assessment protocol. Repeated measurements of outcome measures 
should be performed in order to monitor for any side-effects of the oncological 
intervention, to detect spontaneous recovery and to measure the effects of the speech 
pathology interventions. Apart from baseline measurements, post-treatment and 
follow-up measurements should be used to monitor functional and QoL outcomes.
Additional research is needed to develop clinical practice guidelines to support 
evidence-based practice in the area of dysphagia, speech, voice and trismus following 
radiotherapy and/or chemotherapy in patients with head and neck carcinoma. These 
practice guidelines should bring together the best available current evidence within a 
specific clinical area, formulating evidence-based recommendations for clinicians and 
present choices between different interventions that have an impact on health and 
use of resources [86]. This systematic review summarised the effects of radiotherapy 
and/or chemotherapy on the function of the upper aerodigestive tract in patients with 
head and neck cancer. However, because of the marked variation in treatment 
protocols and patient characteristics, outcome data from the included studies cannot 
easily generalised. Recommendations for future studies advocate the use of a 
multidimensional assessment protocol, using well validated measures and standardised 
pre, post and follow up measurements, thus allowing for future meta-analysis of 
homogeneous outcomes.




The studies included in this systematic review described a wide variety of outcomes in 
patients with HNC following radiotherapy and/or chemotherapy. The findings about 
the long-term functional implications of radiotherapy and/or chemotherapy in patients 
with HNC are inconclusive as a result of the wide range of outcome measures used 
and the possible influence of underreported speech therapy.
Future researchers need to consider targeting more homogeneous groups using 
standardised treatment protocols to improve the treatment outcomes, thereby 
decreasing the side effects of the oncological treatments. Findings of these studies 
need to inform the decision-making process in the treatment of HNC so complications 
can be better predicted with due consideration of the possible negative side effects to 
the upper aerodigestive tract. Although the main objective of most studies was to 
determine curing rates, the importance of the functional implications of the side effects 
of oncology treatments should not be overlooked, particularly their impact on QoL. 
Finally, more research is needed to gain a full understanding of the complexity and 
variety in the effects of effects of radiotherapy and/or chemotherapy on the functions 
of the upper aerodigestive tract following for HNC.
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Effects on quality of life




This study compares the effects of traditional logopedic dysphagia treatment versus 
NMES as adjunct to therapy on quality of life in patients with Parkinson’s disease and 
oropharyngeal dysphagia. Eighty-eight patients were randomized over three treatment 
groups. Traditional logopedic dysphagia treatment or traditional logopedic dysphagia 
treatment combined with NMES at sensor or motor level stimulation were compared. 
Three times (pre-, posttreatment, and three months following treatment), two quality 
of life questionnaires (Swal-QOL MD Anderson Dysphagia Inventory) and a single item 
Dysphagia Severity Scale were scored. The Functional Oral Intake Scale (FOIS) was 
applied to assess the dietary intake.
After therapy all groups showed significant improvement on the Dysphagia Severity 
Scale and restricted positive effects on quality of life. Minimal group differences were 
found. These effects remained unchanged three months following treatment. No 
significant correlations were found between the dietary intake and quality of life. 
Logopedic dysphagia treatment results in a restricted increased quality of life in 
patients with Parkinson’s disease. In this randomized controlled trial, all groups showed 
significant therapy effects on the Dysphagia Severity Scale, as well as restricted 
improvements on the SWAL-QoL and the MDADI. However, only slight non-significant 
differences between groups were found.
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INTRODUCTION
Oropharyngeal dysphagia is a common finding in patients with Parkinson’s disease. It 
is estimated that up to 80% of all patients will suffer from oropharyngeal dysphagia 
during the first stages of the disease. In advanced stages of the disease, the incidence 
of dysphagia can increase up to 95%. [1,2]. Literature describes the main phenomena 
of dysphagia in patients with Parkinson’s disease in terms of rigidity and bradykinesia 
of swallowing. Incomplete cricopharyngeal relaxation, reduced cricopharyngeal 
opening, and delayed initiation of the swallowing reflex have been suggested as 
possible mechanisms of dysphagia in this patient population [3,4]. Furthermore, 
delayed oropharyngeal transition time, reduced muscle strength, as well as aspiration 
are common findings in dysphagic Parkinson patients. [4,5,6].
Dysphagia is associated with malnutrition, dehydration, aspiration pneumonia, and 
sudden death [7,8,9]. Dysphagia is also associated with severe consequences for the 
quality of life of [10,11]. In patients with Parkinson’s disease these consequences 
become more prominent when the disease becomes more invalidating and the ability 
to enjoy oral foods becomes less evident [12,13]. 
Currently, the treatment of dysphagia in patients with Parkinson’s disease exists of 
traditional logopedic dysphagia treatment by a speech therapist. Usually, this treatment 
is provided once or twice a week, for several months or years. Oral motor exercises, 
airway protecting maneuvers, postural correction to facilitate bolus transition, and 
thermotactile stimulation are included in this therapy [14]. The literature regarding 
randomized controlled trials on the outcomes of speech therapy for swallowing 
dysfunction in patients with Parkinson’s disease is scarce. Baijens et al., Nagaya et al. 
and Sharkawi et al. [15,4,16] describe a positive effect of speech therapy on patients 
with Parkinson’s disease and dysphagia, but methodological issues may arise [15]. No 
information is provided about blinding of pre versus posttreatment condition [4] or 
the reliability of measurements using a single assessor or rater [16]. Furthermore, most 
studies base their conclusion on rather small subject populations (N ≤10 subjects).
Neuromuscular electrical stimulation (NMES) can be a therapeutic adjunct to known 
interventions in the treatment of dysphagia [17,18,19]. The rationale of NMES is the 
stimulation of muscle fibres by stimulating the nerve and the motor-end-plate of the 
nerve, resulting in a re-education of the functional muscle-contraction-patterns 
[19,20]. NMES has not been investigated in Parkinson patients with oropharyngeal 
dysphagia yet. 
The aim of this randomized controlled trial is to investigate the effects of adjunctive 
NMES in dysphagic Parkinson patients compared to traditional logopedic dysphagia 
treatment with Health Related Quality of Life (HRQOL) as primary outcome measure. 
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It was hypothesized that NMES would not only contribute to a significant improvement 




A three-arm open randomized trial was set-up to evaluate the hypotheses. Patients from 
diverse hospitals all over the Netherlands, with a diagnosis of idiopathic Parkinson’s 
disease and dysphagic complaints, underwent a standardized clinical examination by a 
laryngologist as well as a clinical observation of the oral intake of various food 
consistencies and volumes by a speech and language pathologist at the outpatient clinic 
of dysphagia in the Maastricht University Medical Center. Only after objectifying the 
presence and severity of oropharyngeal dysphagia, patients were admitted to this study. 
The degree of dysphagic complaints ranged from mild to severe: For example, problems 
of bolus-forming, slow eating, oropharyngeal passage disorder, coughing while drinking, 
abnormal amounts of residue or, severe aspiration. The severity of the Parkinson’s 
disease was assessed using the Hoehn and Yahr (H&Y) disability score [21]. The 
neurological diagnosis was confirmed by the patient’s neurologist. Written informed 
consent was obtained from all patients prior to participation. The study protocol was 
approved by the medical ethical committee of the university medical center.
Inclusion and exclusion criteria
For inclusion in this study the following criteria had to be met: 
1. Diagnosis of idiopathic Parkinson’s disease as confirmed by a neurologist;
2. Patient’s physical condition considered as in a ‘stable’ course of Parkinson’s disease;
3. Unaltered protocol of antiparkinsonian medication for at least two months;
4. Age between 40-80 years old;
5. Presence of oropharyngeal dysphagia with preservation of the swallowing reflex; 
Excluded were the following patients: 
1. Patients with known other neurological diseases (such as Amyotrophic Lateral 
Sclerosis or Multiple Sclerosis); 
2. Patients with severe mental depression or severe cognitive degeneration (Mini 
Mental State Examination < 23);
3. Patients with deep brain stimulation or malignancies, extensive surgery or 
radiotherapy of the head and neck region;
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4. Patients with severe cardiopulmonary diseases, epilepsy, carotid sinus syndrome 
or dermatological diseases of the head and neck;
5. Patients who received dysphagia treatment during the past six months prior to 
randomization.
Sample size and randomization
After a conservative sample size calculation, three intervention groups were formed 
of at least thirty patients per treatment group. Parkinson patients were randomly 
assigned to one of the three treatment groups. Randomization was performed by 
assigning each consecutive patient to the next treatment group; Thus, the first patient 
was assigned to group 1, the second patient to group 2, the third patient to group 3, 
the fourth again to group 1, etc.  
Treatment groups and treatment protocol
Group 1 received traditional logopedic dysphagia treatment (Group TT) by an 
experienced speech therapist. This treatment consisted of oral motor exercises, airway 
protecting maneuvers, and postural compensation based on the dysphagic findings 
as well as the therapist’s individual preference and experience. Group 2  and Group 3 
received the same treatment as Group 1 combined with neuromuscular electrical 
stimulation of the suprahyoidal musculature. In this study, Vitalstim© equipment was 
used (VitalStim® Therapy; frequency 80 Hz, pulse width 700 microseconds; Chattanooga 
Group, Chattanooga, TN, USA). The VitalStim stimulator cycles automatically off for one 
second every minute because of fixed settings by the manufacturer. NMES consisted 
of transcutaneous electrical stimulation by positioning electrodes bilaterally on the 
neck in order to facilitate contraction of the suprahyoidal muscles (Fig 1). Group 2 and 
3 differed in the applied electrical current intensity of the NMES. The neuromuscular 
electrical stimulation of Group 2 (Group NMES-M) was set to stimulate at a motor level, 
to an extend that contractions of the underlying musculature were visible in 
combination with the subjective ‘grabbing sensation’ of the patient. Spasm of the 
musculature was avoided. Group 3 (Group NMES-S) received NMES on a sensory level 
[22].  Therapists received additional training and information on NMES by an 
experienced laryngologist certified to use surface electrical stimulation. The training 
was given according to the manual of the manufacturer, the VitalStim certification 
course (http://www.vitalstim.com) and the study of Ludlow et al. [20,22]. All patients 
were familiarized with the application of the electrical stimulator by their speech 
therapist during training sessions before the onset of the experiment. The therapists 
performed test treatment sessions with NMES on their Parkinson patients in the 
presence of  the laryngologist and speech and language pathologist to ensure 
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standardized application of NMES. The correct placement of the electrodes, the 
application of the NMES unit, and the correct setting of the motorical and sensory 
electrical current thresholds were trained.
Therapies were administered at the patient’s residence by experienced speech 
therapists trained in dysphagia management. In total, eighty-five speech therapists 
were involved in the study. All groups received 13 to 15 dysphagia treatment sessions 
of half an hour each, on five consecutive days per week within a period of three to five 
weeks. All patients were treated within 34 days (median = 23; 25th perc. = 21 and 75th 
perc. = 25 days). The variation in the number of treatment sessions and period duration, 
resulted from daily logistics in clinical practice.
EVALUATION MEASUREMENTS
Baseline characteristics
The following tools (or scales) were used to describe the patient characteristics; The 
Mini Mental State Examination (MMSE) was scored to assess the cognition [23]. The 
MMSE is scaled from 0 to 30, respectively. The Hoehn and Yahr Scale was used to judge 
the severity of Parkinson’s disease [21]. The Hoehn and Yahr Scale ranges from 0 to 5, 
where 0 refers to absence of motor disabilities and 5 indicates bedridden or wheelchair 
dependant motor behavior. All baseline characteristics were determined by an 
experienced laryngologist trained to perform these tests. 
Pre-, Post-, and Follow-up treatment evaluation
As dietary evaluation, the Functional Oral Intake Scale (FOIS) [24] was used (Table 6). 
Two questionnaires on quality of life related to oropharyngeal dysphagia were applied 
in this study: The SWAL-QOL [13] and the MD Anderson Dysphagia Inventory (MDADI) 
[25]. The Dutch translation of the SWAL-QOL, translated and validated by Bogaardt et 
al.[26], was used to determine the quality of life in dysphagic Parkinson patients. This 
44-item questionnaire is a highly valid instrument in evaluating the quality of life 
concerning dysphagia and has a very reliable short-term reproducibility [13]. Its eleven 
subscales represent the different aspects of quality of life. The minimum and maximum 
score range per subscale from 0 to 100, indicating extremely impaired quality of life 
versus no impairment as experienced by the individual. The MDADI consists of 20 items 
and is composed of a global assessment (a single question) and three subscales: The 
emotional, the functional, and the physical subscale. It uses a five-point item scale, 
resulting in a minimum total score of 20 and maximum of 100. The original scoring 
uses a reversed coding in two items. In the Dutch consensus translation and validation 
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[27] all items are rated the same, thus, rewriting two questions. All three measurement 
tools were used to evaluate swallowing function at three time points: pretreatment, 
posttreatment, and at a three months follow-up.  In addition, a visual analogue scale, 
the Dysphagia Severity Scale (DSS), was administered. Using the DSS, the patient self-
reports his swallowing function with a score from 0 to 100 by rating a single question: 
‘How do you qualify your swallowing today?’ Scores can vary from 0 (‘Can’t swallow at 
all’) to 100 (‘Normal swallow’). The DSS was filled in after every treatment session. 
Therefore, the DSS had a maximum of 15 measurement moments. The first two 
measurements were averaged as a baseline and the last two as a posttherapy result. 
The treatment sessions as well as all examinations were performed during the “on” 
motor phase of the Parkinson’s disease [28]. All scales and questionnaires with the 
exception of  the DSS, were rated during a patient’s visit at the outpatient clinic for 
dysphagia in presence of a speech and language pathologist. 
Apart from the above-mentioned evaluation tools, data were gathered on swallowing 
function using videofluoroscopy of the swallowing act and fiberoptic endoscopic 
evaluation of  swallowing (FEES).
Statistical analysis
All data were formally tested for normality with the Kolmogorov-Smirnoff test prior to 
further analysis. The distribution of the data was not sufficiently normal to allow 
parametric statistics. Descriptive statistics of baseline data, effect data (post minus 
pretreatment data), and follow-up minus posttherapy data, were determined. 
Differences between posttherapy and baseline data were tested for significance by a 
Wilcoxon Signed Rank Test. Group differences were tested using a Mann-Whitney U 
test. All statistical analyses were performed using SPSS 15.0 (SPSS Inc., Chicago, IL).
RESULTS
Patient characteristics
After applying inclusion and exclusion criteria, a total of 109 subjects were included in 
this study. All patients were diagnosed with idiopathic Parkinson’s disease having 
oropharyngeal dysphagia. All patients were assigned to one of the three treatment 
groups as described previously. During the period of intervention, 21 subjects were 
excluded because of diverse methodological reasons (change of antiparkinson 
medication N=17, dental surgery N=2, other reasons N=2). The excluded subjects did 
not experience adverse effects from therapy. Furthermore, no significant differences 
in baseline data were present between the group of excluded subjects and the group 
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of included subjects. Finally, 88 patients (65 males, 23 females) did accomplish the full 
period of therapy. The mean age was 68 years, with a range of 42 to 81 years. The 
MMSE ranged from 23 to 30 points (median 28), whereas the Hoehn and Yahr scores 
ranged from 1 to 4 (median 2). No differences were found between the baseline 
characteristics of the three treatment groups. In Table 1 the patients’ characteristics 
for each treatment group separately as well as for all groups combined, are presented.
Treatment effects 
The median and the interquartile range of the stimulation intensities in the NMES-M 
and the NMES-S group were, respectively, 9,5 (7 to 13,75) and 3,25 (2,75 to 4,25) mA. 
Improvement on the Dysphagia Severity Scale during the treatment period is presented 
in Table 2. Table 2 presents the descriptive statistics of the baseline and the effect data 
(post- minus pretreatment data) of the Dysphagia Severity Scale: the median, the 25th, 
and the 75th percentile of a patient’s self-evaluation of dysphagia. The median progress 
on the DSS is 14 points (range -33 to 70). The effect data have been tested for 
significance (Wilcoxon Signed rank test) resulting in a significant positive therapeutically 
effect for all groups. However, no statistically significant differences in effect data were 
found between the three treatment groups (Mann-Whitney U test). 
Table 3 to 5 show the descriptive statistics of both quality of life measurement tools: 
The SWAL-QOL and the MDADI. For each group separately as well as for the total group, 
data are presented. Table 3 and 4 contain, respectively, descriptive statistics of the 
Table 1. Patient characteristics.




Age (years) MMSE H&Y scale
Median 25’;75’ perc. Median 25’;75’ perc. Median 25’;75’ perc.
Group TT 
(N=28)








23;9 66 60;69 28,0 26,5;29,0 2 1,5;3,0
Total Group 
(N=85)
65;25 68 60;73 28,0 26,0;29,0 2 1,0;3,0
a TT = traditional therapy, NMES-M = neuromuscular electrical stimulation at a motor level, NMES-S = 
neuromuscular electrical stimulation at a sensory level.
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baseline data, the effect data, and the follow-up minus posttherapy data of the SWAL-
QOL. A Wilcoxon signed rank test was used to test for significant changes between 
baseline and posttherapy measurements (Table 4). In table 4, only dysphagia-
concerning subscales of the SWAL-QOL are given. Applying a Bonferoni correction, 
both the total group and the TT group showed a significant change on the Symptom 
Index. The total group also presented a significant effect on the Burden scale. No other 
statistically significant results were found. Because of the minimally increased medians 
during the period following therapy (Table 4), no tests were performed to test for 
significant differences between the post- and follow-up data.
Table 5 shows the descriptive statistics of the baseline data, the effect data, and the 
follow-up data minus the posttherapy data for the MDADI and its subscales. To test 
for significant changes between baseline and posttherapy measurements, a Wilcoxon 
signed rank test was used. Following Bonferoni correction, significant therapy effects 
were found for the total group on the total score, the global assessment, and both the 
physical and emotional subscales. None of the groups reached significance on the 
functional subscore. The only other significant effects were found for the TT group and 
the NMES-M group on, respectively, the global assessment score and the total score. 
No significant group differences were found. After three months, the follow-up 
measurement showed ignorable median changes in all treatment groups. Only total 
group changes were tested for significance and indicated at a minor deterioration of 
the global assessment score. 
Descriptive statistics of baseline data and of the effect data, and follow-up minus 
posttherapy data of the Functional Oral Intake Scale, are given in Table 7. The range 
of scores of the FOIS is one to seven, indicating nothing by mouth to total oral diet with 
no restrictions. 
Table 2. Dysphagia Severity Scale (DSS).
Descriptive statistics of the baseline data and the effect data (post- minus pretreatment data), the number of 
patients per treatment group, and the level of significance of the difference between posttherapy data 
compared to baseline data for all groups (Wilcoxon Signed rank test).
Groupa Baseline datab Effect data
Median 25’;75’perc. N Median 25’;75’perc. N P-value
Group TT 59 41;88 28 19 3;44 28 0,000
Group NMES-M 72 52;88 27 10 0;31 27 0,000
Group NMES-S 74 49;87 30 6 -2;24 30 0,005
Total Group 67 49;88 85 14 0;30 85 0,000
a TT = traditional therapy, NMES-M = neuromuscular electrical stimulation at a motor level, NMES-S = 
neuromuscular electrical stimulation at a sensory level.
b The maximum score of the scale is 100.
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Table 6. Functional Oral Intake Scale (FOIS)
Functional Oral Intake Scale for Dysphagia (Crary et al.)
Level 1 Nothing by mouth
Level 2 Tube dependent with minimal attempts of food or liquid
Level 3 Tube dependent with consistent oral intake of food or liquid
Level 4 Total oral diet of a single consistency
Level 5 Total oral diet with multiple consistencies, but requiring special preparation or compensations
Level 6 Total oral diet with multiple consistencies without special preparation, but with specific food 
limitations
Level 7 Total oral diet with no restrictions
Table 7. Functional Oral Intake Scale (FOIS).




Baseline Data Post- minus pretreatment 
data 
Follow-up minus post 
data
Median 25’;75’ perc. N Median 25’;75’ perc. N Median 25’;75’ perc. N
Group  TT 7 6;7 29 0 0;0 29 0 0;0 17
Group NMES-M 7 6;7 29 0 0;0 29 0 -1;0 13
Group NMES-S 7 6;7 29 0 0;0 29 0 0;0 13
Total group 7 6;7 87 0 0;0 87 0 0;0 43
a The maximum score of the scale is 7.
b TT = traditional therapy, NMES-M = neuromuscular electrical stimulation on a motor level, NMES-S = 
neuromuscular electrical stimulation on a sensory level.
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No significant correlations were found between the dietary intake and the quality of 
life questionnaires or the Dysphagia Severity Scale (all R <.2). This finding was also 
observed in the study of Plowman-Prine et al. [11].
DISCUSSION 
The aim of this study is to investigate the effects of NMES in patients with Parkinson’s 
disease and oropharyngeal dysphagia compared to traditional logopedic dysphagia 
treatment with Health Related Quality of Life (HRQOL) as primary outcome measure. 
This study provides positive effects of dysphagia therapy in patients with Parkinson ’s 
disease as found in other studies [15]. One hundred nine subjects have been randomly 
assigned to one of three different treatment groups. All groups show significant therapy 
effects on the Dysphagia Severity Scale, as well as restricted improvements on the 
SWAL-QoL and the MDADI. Using the SWAL-QoL, both the total group and the TT group 
display a significant improvement on the Symptom Index. The total group also presents 
a significant effect on the Burden scale. Using the MDADI, significant therapy effects 
are found for the total group on the total score, the global assessment, and both the 
physical and emotional subscales. For the TT group and the NMES-M group, 
improvements are found on, respectively, the global assessment score and the total 
score. However, only slight non-significant differences between groups are found. 
Additionally, in this study oral-intake related clinical scales do not correlate significantly 
(all R <0.2) with HRQOL related scales. The question arises if the FOIS scale is a 
satisfactory measure for dysphagia severity in this patient population, given the normal 
scores in the present study. The discrepancy between symptoms of dysphagia in daily 
life and oral intake versus the dysphagic findings using swallowing assessment tools 
like FEES or VFS, are known in Parkinson’s disease [29]. The hypothesis that electrical 
stimulation would provide a better outcome on HRQOL can not be confirmed. 
Remarkably is the fact that irrespective of the applied quality of life measurement tool, 
no group differences are found regarding effect data nor follow-up minus posttherapy 
data, thus suggesting the lack of any adjunct therapy effect of NMES.
However, these findings might be explained by other causes as well. One concern might 
lie in the sample size (power). However, according to the sample size calculation, the 
total group (N=88) used for statistical analyses is sufficient. For several, mainly logistic 
reasons, only few patients with severe Parkinson disease (H&Y>3) have been included. 
Usually, this group of patients is admitted to nursing homes, thus not visiting outpatient 
clinics. The moderate severity of Parkinson’s disease in our patient population (H&Y 
scale: median = 2) might have contributed to less significant group differences. If 
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patients would have shown more severe impairments at the beginning of therapy, 
therapy outcome might have been more evident; Theoretically, severely impaired 
subjects can show more improvement on a questionnaire or rating scale than subjects 
who show minor impairments prior to therapy. However, based on literature, it is 
unclear which treatment group would have gained the most benefit in case of a group 
of patients with more severe symptoms of Parkinson’s disease. Furthermore, the 
population of included patients is a realistic representation of Parkinson patients 
consulting speech therapists for dysphagic complaints. Another explanation for the 
absence of group differences can be the treatment period of three weeks. Probably, 
this treatment period is not long enough to observe significant group differences in 
therapy outcome, in spite of the high treatment intensity. Furthermore, the fixed 
stimulation variables (frequency and pulse width) of the VitalStim electrical stimulator 
might not have been optimal for treatment of deglutition disorders in Parkinson’s 
disease. Different stimulation variables can cause different effects in oropharyngeal 
excitability [31]. In Parkinson’s disease swallowing problems can be due to loss of 
neurological control of swallowing rather than muscle weakness or peripheral sensory 
dysfunction [5]. Although sensory and motor effects of this type of electrical stimulation 
have been reported [32,22], this adjunct to traditional logopedic dysphagia treatment 
can be less appropriate for these patients compared to other patient groups. The 
possible effect of electrical stimulation on dysphagia in these patients might be too 
small to be detected at a HRQOL-level. In this study, no adverse effects were observed; 
Ludlow et al. [22] observed that aspiration and pooling were significantly reduced in 
chronically dysphagic patients during surface electrical stimulation with low sensory 
threshold levels of stimulation, whereas almost all subjects showed depression of the 
hyoid bone during motor-level stimulation at rest. The authors hypothesized a higher 
risk of further decreased hyolaryngeal elevation during electrical stimulation in 
dysphagic patients who were already suffering from reduced hyolaryngeal elevation. 
Finally, the lack of significance can not be explained by incompetence of a restricted 
number of speech therapists, since eighty-five speech therapists experienced in 
dysphagia treatment have been involved in this study.  
The application of statistical analyses has been rather conservative in the present study; 
The large number of statistical tests has led to a major impact of the Bonferroni-
correction on the data. 
Summarizing, no convincing arguments or evidence have been found in favor of any 
of the three treatment options studied. Possibly, the use of larger patient groups may 
have revealed minor differences in therapy effects. However, based on our preliminary 
data, no further conclusions can be made.




This study is one of the first attempts to evaluate the effects of adjunct NMES in the 
treatment of Parkinson patients with oropharyngeal dysphagia.  In this randomized 
controlled trial, all groups (TT, NMES-S, and NMES-M) show significant therapy effects 
on the Dysphagia Severity Scale, as well as restricted improvements on the SWAL-QoL 
and the MDADI. However, only slight non-significant differences between groups have 
been found. Although some methodological and clinimetrical issues might arise, most 
of these can be explained by ethical or logistical restrictions. In future, a larger study 
might be needed to clarify these preliminary findings.  
2001816 binnenwerk_Bastiaan Heijnen.indd   68 20-08-18   08:59
69
NMES VS. TRADITIONAL THERAPY FOR PARKINSON’S DISEASE PATIENTS
REFERENCES
1. Nagaya M, Kachi T, Yamada T, Igata A. Videofluorographic study of swallowing in Parkinson’s disease. 
Dysphagia 13: 95-100, 1998.
2. Wintzen AR, Bradrising UA, Roos RAC, Vielvoye J, Liauw L, Pauwels EKJ. Dysphagia in ambulant patients 
with Parkinson’s disease: common, not dangerous. Can J Neurol Sci 21: 53-5, 1994.
3. Ali GN, Wallace KL, Schwartz R, Decarle DJ, Zagami AS, Cook IJ: Mechanisms of oral-pharyngeal dysphagia 
in patients with Parkinson’s disease. J Gastroenterol 110: 383-392, 1996.
4. Nagaya M, Kachi T, Yamada T.Effect of swallowing training on swallowing disorders in Parkinson’s disease. 
Scand J Rehabil Med 32: 11-15, 2000.
5. Ertekin C, Tarlaci S, Aydogdu I, Kiylioglu N, Yuceyar N, Turman AB, Secil Y, Esmeli F. Electrophysiological 
evaluation of pharyngeal phase of swallowing in patients with Parkinson’s disease. Mov Disord 17: 942-
949, 2002.
6. Johnston BT, Li Q, Castell JA, Castell DO. Swallowing and esophageal function in Parkinson’s disease. Am 
J Gastroenterol 90: 1741-1746, 1995.
7. Kirshner HS. Causes of neurogenic dysphagia. Dysphagia 3: 184-188, 1989.
8. Mari F, Matei M, Ceravolo MG, Pisani A, Montesi A, Provinciali L. Predictive value of clinical indices in 
detecting aspiration in patients with neurological disorders. J Neurol Neurosurg Psychiatry 63: 456-460, 
1997.
9. Martin L, Cometti G, Pousson M, Morlon B. Effect of electrical stimulation on the contractile characteristics 
of the triceps surae muscle. Eur J Appl Physiol 67: 457-461, 1993.
10. Gustafsson B, Tibblin L. Dysphagia, an unrecognized handicap. Dysphagia 16: 193-199, 1991.
11. Plowman-Prine, E. K., Sapienza, C. M., Okun, M. S., Pollock, S. L., Jacobson, C., Wu, S. S., et al. The relationship 
between quality of life and swallowing in Parkinson’s disease. Mov Disord 24(9): 1352-1358, 2009.
12. Ekberg O, Hamdy S, Woisard V, Wuttge-Hannig A, Ortega P. Social and psychological burden of dysphagia: 
its impact on diagnosis and treatment. Dysphagia 17: 139-146, 2002.
13. McHorney CA, Bricker DE, Kramer AE, Rosenbek JC, Robbins JA, ChignellKA, Logemann JA, Clarke C. SWAL-
QOL and SWAL-CARE outcomes tool for oropharyngeal dysphagia in adults: I conceptual foundation and 
item development. Dysphagia 15: 115-121, 2000.
14. Crary MA, Groher ME. Introduction to adult swallowing disorders. Elsevier Science USA, 2003
15. Baijens LWJ, Speyer R: Effects of Therapy for Dysphagia in Parkinson’s Disease. Systematic Review. 
Dysphagia 24: 91–102, 2009.
16. Sharkawi AE, Ramig L, Logeman JA, Pauloski BR, RAdemaker AW, Smith CH, Pawlas A, Baum S, Werner C. 
Swallowing and voice effects of Lee Silverman Voice Treatment: a pilot study. . J Neurol Neurosurg 
Psychiatry 72: 31-36, 2002.
17. Bogaardt H, van Dam D, Wever NM, Bruggeman CE, Koops J, Fokkens WJ. Use of neuromuscular 
electrostimulation in the treatment of dysphagia in patients with multiple sclerosis. Ann Otol Rhinol 
Laryngol. 118: 241-6, 2009.
18.  Bulow M, Speyer R, Baijens L, Woisard V, Ekberg O. Neuromuscular electrical stimulation (NMES) in stroke 
patients with oral and pharyngeal dysfunction. Dysphagia. 23: 302-309, 2008.
2001816 binnenwerk_Bastiaan Heijnen.indd   69 20-08-18   08:59
CHAPTER 3
70
19. Freed ML, Freed L, Chatburn RL, Christian M. Electrical stimulation for swallowing disorders caused by 
stroke. Respir. Care 46: 466-474, 2001.
20. Freed M, Wijting Y. VitalStim Certification Program. Training manual for patient assessment and treatment 
using VitalStim electrical stimulation. Hixson TN: Chattanooga Group; 2003.
21. Hoehn NM, Yahr MD: Parkinsonism: onset, progression and mortality. Neurology 17: 427-442, 1967.
22. Ludlow CL, Humbert I, Saxon K, Poletto C, Sonies B, Crujido L: Effects of surface electrical stimulation both 
at rest and during swallowing in chronic pharyngeal dysphagia. Dysphagia 22: 1-10, 2007. 
23. Folstein MF, Folstein SE, McHugh PR : “Mini–mental state”. A practical method for grading the cognitive 
state of patients for the clinician. J Psychiatr Res 12: 189-198, 1975. 
24. Crary MA, Carnaby Mann GD, Groher ME. Initial psychometric assessment of a Functional Oral Intake Scale 
for dysphagia in stroke patients. Arch. Phys. Med. Rehabil. 86: 1516-1520, 2005.
25. Chen AY, Frankowski R, Bishop-Leone J, Hebert T, Leyk S, Lewin J, Goepfert H. The development and 
validation of a dysphagia-specific quality-of-life questionnaire for patients with head and neck cancer. 
Arch Otolaryngol Head Neck Surg. 127: 870-876, 2001.
26. Bogaardt HC, Speyer R, Baijens LW, Fokkens WJ. Cross-cultural adaptation and validation of the Dutch 
version of SWAL-QOL. Dysphagia 24: 66-70, 2009.
27. Speyer R, Heijnen BJ, Baijens LWJ, Vrijenhoef FHE, Otters EFM, Roodenburg N, Bogaardt HCA. Quality of 
life in oncological patients with oropharyngeal dysphagia: Validity and reliability of the Dutch version of 
the Deglutition Handicap Index (DHI) and the MD Anderson Dysphagia Inventory (MDADI) (Under review).
28. Wajsbort J. The “off-on” phenomenon during treatment of Parkinson’s disease with levodopa. J Neurol. 
215: 59-66, 1977.
29. Fuh JL, Lee RC, Wang SJ, Lin CH, Wang PN, Chiang JH, Liu HC. Swallowing difficulty in Parkinson’s disease. 
Clin Neurol Neurosurg. 99: 106-112, 1997.
30. Pollo A, Benedetti F. The placebo response: neurobiological and clinical issues of neurological relevance. 
Prog Brain Res.175: 283-294, 2009.
31. Fraser C, Rothwell J, Power M, Hobson A, Thompson D, Hamdy S: Differential changes in human 
pharyngoesophageal motor excitability induced by swallowing, pharyngeal stimulation, and anesthesia. 
Am J Physiol Gastrointest Liver Physiol. 285: G137-144, 2003.
32. Oh BM, Kim DY, Paik NJ. Recovery of swallowing function is accompanied by expansion of the cortical map. 
Int J Neurosci. 2007;117, 107-119
2001816 binnenwerk_Bastiaan Heijnen.indd   70 20-08-18   08:59
71
NMES VS. TRADITIONAL THERAPY FOR PARKINSON’S DISEASE PATIENTS
2001816 binnenwerk_Bastiaan Heijnen.indd   71 20-08-18   08:59
4
2001816 binnenwerk_Bastiaan Heijnen.indd   72 20-08-18   08:59
1  Department of Otorhinolaryngology and Head and Neck Surgery, Leiden University Medical Centre, Leiden, 
The Netherlands.
2 College of Healthcare Sciences, James Cook University, Townsville, Queensland, Australia. 
3 Diagnostic Centre of Imaging and Functional Medicine, Malmö, Sweden. 
4 Department of Clinical Sciences, Lund University, Malmö, Sweden.  
5 Skane University Hospital Malmö, Malmö, Sweden.  
6 Department of Clinical Sciences, Institute of Tropical Medicine, Antwerp, Belgium.
Published in: Dysphagia. 2016 Apr;31(2):214-22.
BJ Heijnen1, R Speyer2,1, M Bulow3,4,5,  LMF Kuijpers6
‘What about swallowing?’ 
Diagnostic performance
of daily clinical practice 
compared with the 
Eating Assessment 
Tool -10





In daily clinical practice, patients are frequently asked about their swallowing as part 
of the patient-clinician interview. This study compares the diagnostic performance of 
a single open question ‘What about swallowing?’ (usual care) with the Eating Assessment 
Tool (EAT-10) as reference test in screening for oropharyngeal dysphagia (OD).
Materials and methods
303 outpatients at risk of OD were recruited at three university hospitals: 162 men and 
141 women with a mean age of 70 years. All data were retrieved by phone. 
Results
To identify patients at risk of dysphagia, two different cut-off scores for the EAT-10 
total score were retrieved from the literature. The diagnostic performance of the single 
question was determined by comparing dichotomized answers to the single question 
(no problems versus difficulties in swallowing) with the EAT-10 as reference test. 
Sensitivity, specificity, positive and negative predictive values ranged between 0.75-0.76, 
0 .75-0.84, 0 .93-0.97 and 0.38-0.43, respectively. 
Discussion and Conclusion
Mostly, the results of this exploratory study indicate a sufficient diagnostic performance 
of the single question in identifying patients who are at risk of dysphagia when using 
the EAT-10 questionnaire as a reference test.  Further research, is, however, necessary 
to provide additional psychometric data on Functional Health Status (FHS) 
questionnaires including the single question using either FEES or VFS as gold standard 
or reference test.




Oropharyngeal dysphagia (OD) is associated with malnutrition, dehydration, aspiration 
pneumonia, and sudden death [1, 2]. It is known to affect social life[3]: patients may 
no longer enjoy eating and drinking, and may avoid social activities.  OD may, therefore, 
have a major impact on a patient’s Health-Related Quality of Life (HR-QoL)[2-4]. 
HR-QoL is the effect of (chronic) medical conditions and their treatment on daily 
functioning and quality of life (QoL)[5], which is ‘‘a state of complete physical, mental 
and social well-being, not merely the absence of disease or infirmity’’[6], as defined by 
the World Health Organization (WHO) in 1946[6]. A recent systematic review by 
Timmerman et al.[7] gives an overview of HR-QoL questionnaires regarding dysphagia. 
Examples of these questionnaires are the Dysphagia Handicap Index (DHI)[8], the M.D. 
Andersen Dysphagia Inventory[9] and the SWAL-QOL[10-12]. 
The gold standard for detecting dysphagia is fibre optic endoscopic evaluation of 
swallowing (FEES)[13] or video fluoroscopy of the swallowing act (VFS)[13, 14]. The 
importance of detecting OD at an early stage is being recognized more frequently. 
Most examinations can, however, be burdensome, time-consuming and costly [15], 
and therefore, not performed as routine clinical practice in every patient visiting an 
otorhinolaryngology department. 
Another way of screening for OD is the use of a Functional Health Status (FHS) 
questionnaire., which quantifies the influence of a given disease on particular functional 
aspects as experienced by the patient[4]. In OD, FHS questionnaires quantify the 
severity of the swallowing problem [4, 16]. A recent systematic review by Speyer et 
al.[4]  retrieved three English-language questionnaires on FHS in adults with OD: the 
Eating Assessment Tool (EAT-10)[17], the Swallowing Outcome after Laryngectomy 
(SOAL)[18], and the Self-report Symptom Inventory. The Sydney Swallow Questionnaire 
(SSQ)[19] proved to be identical to the Modified Self-report Symptom Inventory.
The Eating Assessment Tool (EAT-10) by Belafsky et al.[17] is a short 10-item, easy to 
use, self-administered questionnaire[4]. Although the EAT-10 is considered to be 
predominantly a questionnaire on FHS, some items on HR-QoL are also included. The 
sum score of this 10-item questionnaire ranges from 0 to 40[17]. Belafsky et al.[17] 
found that a sum score ≥3 indicates that a patient is at risk of dysphagia and warrants 
further examination. In a recent study by Rofes et al.[20], however, it was determined 
that a cut-off score ≥2 would be optimal.  Rofes et al. [20] calculated the sensitivity and 
specificity of the EAT-10 using VFS as a reference test (golden standard[21]). By using 
a cut-off score of ≥2, the sensitivity and specificity for OD was 89% and 82%, respectively. 
Lately Cheney et al. [22] evaluated the ability of the EAT-10 to screen for aspiration risk 
in patients with dysphagia describing a cutoff score of > 15: sensitivity 71% and 
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specificity 53%. As Cheney et al. used the EAT-10 not just to screen for OD but to screen 
for aspiration in selected patients with OD, cut-off points differed highly from earlier 
data by Belafsky et al. [17] and Rofes et al. [20]
In daily clinical practice, however, a single question such as ‘What about swallowing?’ 
is frequently used without any additional standardized testing. For example, general 
practitioners may restrict their patient history on swallowing to a single question, 
whereas clinicians in specialized dysphagia clinics will include standardized 
questionnaires such as the EAT-10 as part of the assessment and management of 
dysphagia. The diagnostic performance of a single question has not been explored 
until now. If a patient’s answer was negative, it is possible that no further swallowing 
screening or assessment would be performed. As symptoms like coughing, choking, 
feeling the food sticking (in the throat) after swallowing and respiration problems may 
all be aspects of OD, a single question might expect a patient to have preliminary 
knowledge about the concept of dysphagia. Therefore, the use of a single question on 
swallowing instead of a more detailed questionnaire such as the EAT-10, might lead 
to an under-diagnosis of those patients at risk of dysphagia.  
The purpose of the current study is to compare the diagnostic performance of a single 
question on swallowing (usual care) with the FHS questionnaire EAT-10 as reference 
test.  Two different EAT-10 cut-off scores for patients at risk of dysphagia will be used: 
a sum score ≥3 as suggested by Belafsky et al.[17] and ≥2 as defined by Rofes et al.
[20]. We hypothesize that a single question, ‘What about swallowing?’, which is part of 
everyday clinical practice, will show poor diagnostic performance when compared to 
the EAT-10. It is expected that the single question will have insufficient sensitivity and 
specificity to identify patients at risk of dysphagia.
METHODS
Subjects
We studied a consecutive series of new patients who visited the outpatient clinics for 
dysphagia or otorhinolaryngology of the Leiden University Medical Centre (LUMC), 
Maastricht University Medical Centre (MUMC) and Skane University Hospital Malmö 
(SUS Malmö). Included were participants aged at least 18 years of age who might be 
at risk of OD. Patients with severe cognitive problems were excluded. Within six months 
of their initial visit to the clinics, patients were contacted by telephone. All data was 
collected during that call. 




First, patients were invited to participate when contacted by phone. After informed 
consent and during that same phone call, data on the current status of the patients 
were collected. Subject characteristics including age, gender and actual oral intake 
were registered. The latter was assessed using the Functional Oral Intake Scale (FOIS) 
which ranges from 1 (i.e., nothing by mouth) to 7 (i.e., no restrictions)[23]. Subsequently, 
a single question was posed, representing clinical daily practice: ‘What about 
swallowing?’. All answers were written down and at a later stage dichotomized, to 
normal (i.e., no complaints) and abnormal (i.e., at least mild complaints). For example, 
participants responded ‘I can eat and drink everything’ (normal) or ‘Sometimes meat 
gets stuck in my throat’ (abnormal). Finally, the EAT-10 was administered. The EAT-10 
consists of ten questions which can be scored from 0 (no problem) to 4 (severe 
problem). The range of the sum score is 0 to 40[17].
Statistics
Apart from descriptive data analysis, the sensitivity, specificity, positive predictive value 
(PPV) and negative predictive value (NPV) of the single question ‘What about swallowing?’ 
were calculated. The EAT-10 was used as a reference test. A sensitivity of ≥70% and a 
specificity of ≥60% was considered as minimum requirement for screening 
instruments[24]. Both cut-off scores by Belafsky et al.[17] and Rofes et al.[20] were 
used to identify patients at risk of dysphagia.  
RESULTS
The LUMC, MUMC and SUS Malmö included 303 patients (78, 122 and 103 patients, 
respectively).  Patient characteristics are provided in Table 1. One hundred and sixty-
two patients (53%) were male with a median age of 70 years (IQR, 60-77 years), and 
141 were female with a median age of 69 years (IQR, 57-76 years). Medical diagnoses 
included head and neck cancer (15%) and neurological diseases such as stroke, 
Parkinson’s disease, multiple sclerosis or myotonic dystrophy (46%). A third group of 
patients suffered from a variety of diseases such as general weakness due to other 
diseases, cricopharyngeus hypertrophia, epiglottitis etc.(39%). Most patients followed 
an oral intake without any restrictions: The median FOIS score was 7 (IQR, 5-7). 
Figure 1A shows the FOIS levels in relation to the dichotomized EAT-10 scores using a 
cut-off score of ≥3 points according to Belafsky et al.[11] to distinguish patients at risk 
of dysphagia and those demonstrating normal swallowing. The data in the figure 
indicates that 36.0% of the total population obtained an abnormal EAT-10 score, thus 
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being at risk of dysphagia, while oral intake was normal, whereas 2.3% of the total 
population obtained a normal EAT-10 score while their oral intake was restricted. This 
may suggest that a cut-off point of ≥3 misses 2.3% of participants who seem at risk of 
dysphagia. When using the cut-off score of ≥2 points by Rofes et al. [20], the following 
data are found (see Figure 1B): 38.9% of the total population producing an abnormal 
EAT-10 score have a normal oral intake, whereas 1.0% of those with a normal EAT-10 
score have an oral intake with restrictions.
Figure 2A displays the answer to the single question ‘What about swallowing?’ in relation 
to the EAT-10 outcome using the cut-off score by Belafsky and underlines the previous 
findings shown in Figure 1A. A total of 200 (66.1%) patients report having swallowing 
problems when answering the single question. Two-hundred and forty-four of these 
patients were at risk of dysphagia according to the EAT-10. In 103 patients (34.0%) the 
single question was scored as normal; however, 59 (19.5%) of these patients were at 
risk of dysphagia according to the EAT-10. Figure 2B shows similar data using the cut-
off score by Rofes et al.[20]. In 103 patients (34%), the single question was scored as 
normal; however, 64 (21.1%) of these patients were at risk of dysphagia according to 
the EAT-10.
In Figure 3, the distribution is displayed of the answers to the single question versus 
the EAT-10 total score. The histogram shows that the patients who report having no 
swallowing problem on the single question can score ≥3 points on the EAT-10, with 
some patients having EAT-10 sum scores up to 32.
Table 1. Subject characteristics (number of subjects, gender, age, FOIS and medical diagnoses per center.
Subject characteristics Patient recruitment (Centre) Total 
LUMC SUS Malmö MUMC
Number of subjects 78 103 122 303
Gender (M;F) 34 M; 44 F 50 M; 53 F 78 M; 44 F 162 M; 141 F
Age in yrs
(Med; IQR)
All 67; 53-76 74; 64-79 69; 62-74 70; 60-77
Male 67; 56-71 75; 66-79 69; 64-75 70; 63-77
Female 69; 50-76 73; 62-79 68; 55-73 69; 57-76
FOIS (Med; IQR) 7; 6-7 6; 5-7 6; 5-7 7; 5-7
Medical diagnoses 
(N; %)
Head and Neck 
cancer
27; 35 3; 3 16; 13 46; 15
Neurological 
disorder
16; 20 28; 27 95; 78 139; 46
Other 35; 45 72; 70 11; 9 118; 39
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Table 2 shows the frequencies of the EAT-10 scores per item for three groups: all 
participants (N=303), subjects with normal swallowing (N=103) and those with abnormal 
swallowing (N=200) according to the single question. In addition, Figure 4 illustrates 
the sum of all total scores per EAT-10 item for the same three groups; higher scores 
were obtained for items 2, 4 and 8 and lower scores for items 1 and 6. All three groups 
showed similar tendencies.
The diagnostic performance of the single question was determined using the EAT-10 
as reference test and the single question as index test (Table 3). Table 3A and 3B 
present cross-tabs based on the cut-off sum score according to Belafsky et al.[17] and 
Rofes et al. [20], respectively. Using a cut-off score of ≥3, the following data are found: 
sensitivity of 76%, specificity of 75%, PPV of 93% and NPV of 43% (Table 3A). Changing 
the EAT-10 cut-off score to ≥2 points increases specificity to 84% and PPV to 97%, and 
decreases the sensitivity to 75% and NPV to 38% (Table 3B). 
Figure 1A.
FOIS levels in percentages by dichotomized EAT-10 
scores (cut-off score ≥3) [17]
Figure 1B.
FOIS levels in percentages by dichotomized EAT-10 
scores (cut-off score ≥2) [20]













































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Subjects at risk of OD: Data on single question by 
dichotomized EAT-10 scores (cut-off score ≥3) [17].
Figure 2B.
Subjects at risk of OD: Data on single question by 
dichotomized EAT-10 scores (cut-off score ≥2) [20].
Table 3A Cross-tabs of the EAT-10 using a cut-off score of ≥3 [11] (Reference test) and the single question “What 
about swallowing?” (Index test). Diagnostic performance of the single question: Se=0.76, Sp=0.75, PPV=0.93 
and NPV=0.43.
EAT-10 (Reference test) Total
+












Total 244 59 303
Table 3B Cross-tabs of the EAT-10 using a cut-off score of ≥2 [12] (Reference test) and the single question (Index 
test). Diagnostic performance of the single question: Se=0.75, Sp=0.84, PPV=0.97 and NPV=0.38.
EAT-10 (Reference test) Total
+












Total 257 46 303




The purpose of the current study was to compare the diagnostic performance of a single 
question on swallowing with the FHS questionnaire EAT-10 as a reference test to identify 
patients who are at risk of dysphagia. Although it may be hypothesized that a validated 
questionnaire may have a higher sensitivity and specificity, a single question is still part 
of everyday clinical practice and, therefore, its diagnostic performance should be known. 
For example, most general practitioners may restrict their patient history on swallowing 
to a single question, whereas clinical experts in OD will ask for more detailed information 
and will usually include standardized assessments on OD such as the EAT-10. 
The use of a measurement tool in clinical practice can only be justified by its validity 
and reliability. When validating questionnaires, different psychometric characteristics 
should be taken in account as shown by Terwee et al.[25] and Aaronson et al.[26] such 
as content validity, internal consistency, criterion validity, construct validity, 
reproducibility,  responsiveness, floor and ceiling effects, and  interpretability . In 2010, 
Mokkink et al.[27] published the Consensus-based Standards for the selection of health 
Measurement  Instruments (COSMIN)[28]: a taxonomy of measurement properties 
and definitions for health-related patient reported outcomes.  
Figure 3. Distribution of data on single question by EAT-10 total score.
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In a psychometric review by Speyer et al. [4]on FHS in OD, three FHS questionnaires 
were retrieved whose measurement properties were determined using the COSMIN 
checklist[29] and the 4-point rating scale according to Terwee et al.[30] All three FHS 
questionnaires obtained poor overall methodological quality scores for most 
psychometric properties and, therefore, psychometric re-assessment of all FHS 
questionnaires was advised. In a more recent publication, Rofes et al.[20] provided 
additional information on the diagnostic performance of the EAT-10 compared with 
VFS. The EAT-10 showed an ROC AUC of 0.89 for OD with an optimal cut-off score at 
two instead of the proposed cut-off at three by Belafsky et al.[17]. The sensitivity and 
specificity were 0.89 and 0.82, respectively. 
In this study, we demonstrated that a single question has sufficient sensitivity and 
specificity to screen for patients at risk of dysphagia when using the EAT-10 as reference 
test; depending on the EAT-10 cut-off point, sensitivity and specificity of the single 
question ranged between 75 to 76% and 75 to 84%, respectively. These values fall 
within the minimum norms for sensitivity and specificity of ≥ 70% and ≥ 60% as 
suggested by Bours et al.[21] or Kertscher et al.[24].  This leads to the rejection of our 
initial hypothesis that a single question ‘What about swallowing?’ would show poor 
diagnostic performance when compared to the EAT-10. 
However, despite of the sufficient sensitivity and specificity, the low NPV of the single 
Figure 4. Sum of all total scores per EAT-10 item for all subjects (N=303) and subjects with abnormal swallowing 
(N=200) and normal swallowing (N=103) according to the single question.
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question (ranging between 0.38 and 0.43 depending on the cut-off point) remains a 
concern and may restrict the use of the single question in screening for dysphagia; a 
high percentage of subjects (false negatives) will not be considered for further 
dysphagia assessment even though they are actually at risk for dysphagia. In contrast 
to the NPV, the PPV (ranging between 0.93 and 0.97) is adequate and only very few 
subjects (false positives) will be referred for further assessment while not being at risk 
for dysphagia.  
Some methodological remarks can be made, however. First of all, in this study, a 
Swedish and Dutch consensus translation by dysphagia experts of the EAT-10 was 
used. These translations were not validated. Furthermore, all data were gathered by 
phone, whereas the EAT-10 was developed as a patient self-report. Another aspect is 
the possible priming of patients using a standardized protocol order: the single 
question was asked first, directly followed by the EAT-10. Finally, the subject population 
in general showed limited restrictions in oral intake as measured by FOIS, indicating a 
mild severity of OD. It cannot be ruled out that in the case of patients with more severe 
swallowing problems, data might have been slightly different from those presented in 
this manuscript. In our opinion, however, none of these matters is expected to be of 
significant influence on the reported outcome.
Nonetheless, even though the single open question showed sufficient diagnostic 
performance, the use of a standardized questionnaire may have advantages. Using a 
standardized set of questions warrants the retrieval of similar information from all 
patients and prohibits the omission of essential information. Furthermore, in contrast 
to the single question, patients do not need to have preliminary knowledge about the 
concept of dysphagia. A questionnaire could list all associated issues such as coughing, 
history of pneumonia, etc. Still, in case of the availability of multiple screening tools 
with sufficient diagnostic performance, different clinical work settings may require 
different screening tools depending on factors such as number of trained staff, work-
load per staff member, availability of FEES or VFS in the setting itself, and possible time 
constraints[24]. 
Currently, research is being carried out to determine the diagnostic performance of 
FHS questionnaires including the single question using either FEES or VFS as reference 
test. This study will provide additional psychometric data on FHS questionnaires as a 
screening instrument for patients at risk of OD and the validity and reliability of a single 
question representing daily clinical practice. 




Because OD is associated with malnutrition, dehydration, aspiration pneumonia, 
sudden death[1, 2], decreased HR-QoL[7] and is often a complication of other medical 
problems[31], early detection and adequate screening are important.  A single open 
question ‘What about swallowing?’ is often part of daily clinical practice.
Even though the NPV was rather low, this study found high sensitivity, specificity and 
PPV data for this single question in identifying patients who are at risk of dysphagia 
when using the EAT-10 questionnaire as a reference test. Ongoing research will provide 
additional psychometric data on FHS questionnaires such as the single question using 
either FEES or VFS as gold standard or reference test. Once the measurement properties 
of all FHS questionnaires, including daily clinical practice or the single open question, 
are known, an optimal choice between FHS questionnaires can be justified.
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Quality of life is considered to be an important outcome measurement in objectifying 
the current health status or therapy effects in patients with oropharyngeal dysphagia. 
In this study, the validity and reliability of the Dutch version of the Deglutition Handicap 
Index (DHI) and the MD Anderson Dysphagia Inventory (MDADI) have been determined 
in oncological patients with oropharyngeal dysphagia. 76 consecutive patients were 
selected at the Medical University Hospital Maastricht and were asked to fill in three 
questionnaires on quality of life related to oropharyngeal dysphagia (the Swal-Qol, the 
MDADI, and the DHI) and a simple one-item visual analogue Dysphagia Severity Scale. 
None of the quality of life questionnaires showed any floor or ceiling effects. The test 
retest reliability of the MDADI and the Dysphagia Severity Scale proved to be good. 
The test retest reliability of the DHI could not be determined because of insufficient 
data. However, the intraclass correlation coefficients were rather high. The internal 
consistency proved to be good. However, when applying confirmatory factor analysis, 
the underlying constructs as defined by the subscales per questionnaire could not be 
distinguished. When considering the criterion validity, the MDADI as well as the DHI 
showed satisfactory associations with the Swal-Qol (reference or gold standard) after 
having removed its less relevant subscales. 
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INTRODUCTION
Patients with advanced head and neck cancer often suffer from oropharyngeal 
dysphagia as a result of the disease itself or its treatment1. Dysphagia can lead to 
malnutrition and dehydration as well as an increased risk of aspiration2. When 
objectifying a patient’s current health status as well as the effects of a therapeutic 
intervention, quality of life is considered to be an important evaluation tool3.
In the literature, a few questionnaires on health related quality of life can be found 
that focus on oropharyngeal dysphagia: The Swal-Qol4, the MD Anderson Dysphagia 
Inventory (MDADI)5, and the Deglutition Handicap Index (DHI)6. When using a 
questionnaire in research, its psychometric characteristics must be well-known and of 
sufficient high quality, otherwise, the study results cannot be interpreted or be given 
any clinical relevance. Although the reliability and validity of the Swal-Qol has been 
described4, hardly any data are available on the psychometric quality of the MDADI or 
the DHI. The Swal-Qol is an elaborated 44-item questionnaire containing eleven 
subscales. Although the Swal-Qol is a commonly used instrument in research, its 
application in daily clinical practice may be limited. Clinicians need a short, easy-to-
handle questionnaire for clinical screening.
In this study, the validity and the reliability of the Dutch version of the DHI and the 
MDADI in oncological patients with oropharyngeal dysphagia will be determined.
METHODS
Subjects
Patients were selected consecutively at the outpatients’ clinic for dysphagia at the 
Department of Otorhinolaryngology, Head and Neck Surgery and at the MAASTRO 
clinic at the Medical University Hospital in Maastricht (MUMC). Patient recruitment took 
place during outpatients’ visits at the outward patient clinic. A small sample of included 
patient was recruited by phone after having studied their medical records. All included 
patients had to meet the following criterion; the patients had to be diagnosed by a 
laryngologist as having oropharyngeal dysphagia based on oncological disorders. 
Furthermore, a patient’s general condition had to be considered as stable during 
repeated measurements. Lastly, included patients may not show any cognitive 
restrictions. Patients received oral information about the study and were only included 
after informed consent. 
In total, 76 patients were included in the study. There were 57 (75%) men and 19 (25%) 
women in this study, with an age ranging from 45 to 83 years. The mean age for men 
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and women was, respectively, 64 and 61. The status of the oral feeding restrictions 
was scored, using the Functional Oral Intake Scale or FOIS by Crary et al.7. Two subjects 
were tube dependent, while all other subjects were on a total oral diet varying from a 
diet with a single consistency (N=7), with multiple consistencies and special preparation 
or compensation (N=30), without any special preparation but with some food limitations 
(N=28), to a normal oral diet (N=9).
Questionnaires
Four questionnaires have been used in this study; Three questionnaires on quality of 
life related to oropharyngeal dysphagia, namely, the Swal-Qol4, the MD Anderson 
Dysphagia Inventory (MDADI)5, the Deglutition Handicap Index (DHI)6, plus a simple 
one-item visual analogue scale (Dysphagia Severity Scale). Both the MDADI and the 
DHI were translated into Dutch by three independent researchers and combined into 
one final translation by mutual consensus. The Dysphagia Severity Scale needed no 
translation and the Swal-Qol had already been translated by Bogaardt et al.8.
The first questionnaire, the Swal-Qol, is considered to be the golden standard for 
determining quality of life in oropharyngeal dysphagia. This 44-item tool exhibits good 
internal-consistency reliability and short-term reproducibility4. It consists of eleven 
subscales (see Table 1). The minimum and maximum score per subscale are zero and 
100, indicating extremely impaired quality of life versus no impairment as experienced 
by the individual. The DHI is a 30-item questionnaire on deglutition related aspects in 
daily life (5 point-rating scale: 0-4). The questionnaire is subdivided in three domains 
of ten items: emotional (psychosocial consequences), functional (nutritional and 
respiratory consequences) and, physical (symptoms related to swallowing), The 
minimum score is zero points (indicating no handicap) and the maximum score is 120 
points (indicating maximum handicap)6. The MDADI consists of 20 items. It is composed 
of a global assessment (a single question) and three subscales, namely, the emotional 
subscale (eight items), the functional subscale (five items), and the physical subscale 
(six items). The global assessment refers to the individual’s swallowing difficulty 
affecting the overall daily routine. The emotional, functional, and physical subscales 
refer to the individual’s affective response to the swallowing disorder, the impact of 
the disorder on daily activities, and the self-perceptions of the swallowing difficulties, 
respectively5. Using five-point scales (1-5), the minimum total score is 20 and the 
maximum total score is 100. In the original version of the MDADI, all but two items 
were scored in a way that higher scores referred to higher functioning. In the Dutch 
translation, it was decided to use a uniform way of scoring. Thus, by adjusting the 
scoring of two items, low scores refer to low functioning, whereas high scores refer to 
high functioning. The Dysphagia Severity Scale is a self-designed evaluation tool, 
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consisting of one visual analogue scale, quantifying the severity of the swallowing 
disorder and the extent of impairment experienced by the patient. A score of 100 (the 
maximum) indicates normal swallowing abilities, while a score of zero indicates extreme 
swallowing impairment or inability to swallow. 
Protocol
Patients were asked to fill in all four questionnaires during their outpatients’ visit or 
when recruited by phone, at home. Within two weeks after the first measurement9, all 
patients received by post the MDADI, the DHI and the Dysphagia Severity Scale for 
repeated measurements purposes. The researchers made sure that all repeated 
Table 1. Descriptive analysis of the MD Anderson Dysphagia Inventory (MDADI), the Deglutition Handicap Index 
(DHI), the Dysphagia Severity Scale, and the Swal-Qol.






Burden 0 – 100 63 (6;75) 73
Food Selection 0 – 100 75 (25;88) 71
Eating Duration 0 – 100 25 (0;63) 71
Eating Desire 0 – 100 75 (27;100) 72
Fear 0 – 100 88 (69;100) 71
Sleep 0 – 100 75 (44;88) 73
Fatigue 0 – 100 58 (33;83) 73
Communication 0 – 100 63 (50;88) 71
Mental Health 0 – 100 65 (30;90) 71
Social Functioning 0 – 100 65 (25;92) 73




Total Score 0 – 120 36 (20;46) 42
Emotional Subscore 0 – 40 10 (2;22) 46
Functional Subscore 0 – 40 12 (8;19) 44






Total Score 20 – 1002 66 (51;77) 74
Global Assessment 1 – 5 4 (2;4) 76
Emotional Subscore 6 – 30 20 (15;25) 75
Functional Subscore 5 – 25 17 (13;21) 75
Physical Subscore 8 – 40 25 (19;29) 75
Dysphagia Severity Scalea 0 – 100 49 (34;71) 57
a Lower scores indicate more severely impaired quality of life or ability to swallow (MDADI, Dysphagia Severity 
Scale, Swal-Qol). b Higher scores indicate more severely impaired quality of life (DHI). c According to Chen et al. 
(2001) the range of scores is zero to 100, while using a scale of 1 to 5. In this study the range of scores has been 
adjusted.
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measurements were sent back in time for adequate retest interval analysis9, reminding 
patients if necessary by phone.
Statistical analysis
Table 2 presents a glossary of psychometric and statistical terminology as used in this 
study. Measurement properties of the MDADI and the DHI were determined and 
compared to the quality criteria as defined by Terwee et al.10. 
Firstly, both questionnaires were examined for possible floor and ceiling effects by 
objectifying the number of respondents achieving the lowest or highest possible scores. 
Next, the test retest reliability was assessed by determining intraclass correlations 
coefficients (two-way random effects model, ICC) between repeated measurements 
on the MDADI, the DHI and the Dysphagia Severity Scale. Confirmatory Maximum 
Likelihood (ML) factor analyses were performed to determine the number of 
(homogeneous) (sub)scales of each questionnaire. In addition, by computing Cronbach’s 
α coefficients, the internal consistency reliability of the MDADI and the DHI was 
estimated. The associations among the four administered questionnaires plus the 
FOIS, and among the subscales per instrument have been determined by nonparametric 
Spearman’s correlation coefficients. (Sub)scales from the MDADI and the DHI that were 
supposed to measure the same concept were compared, thus, defining construct 
validity (convergent validity). Finally, the criterion validity was determined by 
computing nonparametric Spearman’s correlations between the Swal-Qol (reference 
or gold standard) and both the MDADI and the DHI. All statistical analyses were 
performed using SPSS 15.0.
RESULTS
Table 1 presents the descriptive statistics for all four questionnaires. To examine 
possible floor or ceiling effects, the total score of the MDADI, the total score of the 
DHI, and the Dysphagia Severity Scale have been visualized by means of histograms 
(Figure 1A, 1B, and 1C), thus, objectifying the number of respondents achieving the 
lowest or highest possible scores. As less than 15% of the respondents achieved the 
lowest or highest possible score, no floor or ceiling effects are considered to be 
present10. 
To assess the test retest reliability, intraclass correlation coefficients (two-way 
random effects model, ICC) have been determined between repeated measurements 
on the total scores of the MDADI and the DHI, as well as on the Dysphagia Severity 
Scale. The ICC’s were respectively, .96, .94, and .87. A positive rating for reliability can 
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only be given when the ICC is at least 0.70 in a sample size of at least 50 patients10. 
Because of missing values, the actual sample sizes used for ICC computation were 64 
(MDADI), 35 (DHI) and, 49 (Dysphagia Severity Scale). Therefore, in case of the DHI, the 
reliability could not be determined appropriately, as a consequence of too few data. 
Both other two instruments are considered to have good test retest reliability.
Table 2. Glossary of psychometric and statistical terminology.
Terminology Definition
Construct validity The extent to which a measurement corresponds to theoretical concepts 
(constructs) concerning the phenomenon under study15.
Convergent validity Convergent validity refers to the degree to which a measure is correlated with 
other measures that it is theoretically predicted to correlate with. In contrast, 
discriminant validity describes the degree to which the measure is not similar to 
(diverges from) other measures that it theoretically should not be similar to. 
Convergent validity and discriminant validity are variants of construct validity15.
Correlation coefficient An index that quantifies the linear relationship between a pair of variables (range 
-1 to 1) with the sign indicating the direction of the relationship and the 
numerical magnitude its strength. Values of -1 or 1 indicate that the sample 
values fall on a straight line, whereas a value of zero indicates the lack of any 
linear relationship between the two variables16.
Criterion validity The extent to which the measurement correlates with an external criterion of the 
phenomenon under study15.
Cronbach’s alpha The estimate of the correlation between the total score across a series of items 
from a rating scale and the total score that would have been obtained had a 
comparable series of items been employed.15 Cronbach’s alpha is an index of 
internal consistency of a psychological test ranging from 0 to 1. (Guidelines for 
interpretation: < 0.60 unacceptable, 0.60-0.65 minimally acceptable, 0.70-0.80 
respectable, 0.80-0.90 very good, and > 0.90 consider shortening the scale by 
reducing the number of items17.)
Factor analysis A set of statistical methods (e.g. maximum likelihood estimation), for analyzing 
the correlations among several variables in order to estimate the number of 
fundamental dimensions that underlie the observed data and to describe and 
measure those dimensions15. These underlying, unobservable, latent variables, 
are usually know as the common facors17. Using exploratory factor analysis, no 
hypothesis about the number and kind of common factors exists prior to 
analysis. In case of confirmatory factor analysis, the number of common factors 
has been predetermined.
Floor or ceiling effect The number of respondents who achieved the lowest or highest possible score10.
Goodness of fit The degree of agreement between an empirically observed distribution and a 
mathematical or theoretical distribution15.
Internal consistency The extent to which items in a (sub)scale are intercorrelated, thus measuring the 
same construct10.
Intraclass correlation The proportion of variance of an observation due to between-subject variability 
in the ‘true’ scores of a measuring instrument16.
Test retest reliability An index of score consistency over a brief period of time (typically several weeks), 
usually the correlation coefficient determined between administration of the test 
twice with a certain amount of time between administrations16.
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Internal consistency is an important measurement property for questionnaires and 
describes the extent to which items in a questionnaire (sub)scale are correlated, thus 
measuring the same concept. In case of an existing theoretical model or because the 
factor structure has been determined previously, confirmatory factor analysis should 
be applied in order to determine the number of (homogeneous) (sub)scales. Therefore, 
a confirmatory Maximum Likelihood (ML) factor analysis has been performed using all 
items of the MDADI to test whether three factors could be distinguished (namely, the 
three subscales). However, this three-factor model was rejected (goodness-of-fit test, 
Figure 1A. Data distribution on the MDADI Figure 1B. Data distribution on the DHI
Figure 1C. Data distribution on the Dysphagia Severity Scale
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p<.000). A four-factor model referring to the global assessment as possible fourth 
factor, was rejected as well (p=.003). A confirmatory ML factor analysis using all items 
of the DHI and a three-factor model resulted too in rejection of the possibility of three 
underlying constructs or subscales (goodness-of-fit test, p<.000).
Still, as the subject population was rather limited, further analysis was performed to 
gather more information about the questionnaires’ psychometric properties. 
Cronbach’s alpha has been determined as it is considered an adequate measure of 
internal consistency reliability. Low Cronbach’s alpha’s suggest lack of correlation (α ≤ 
0.70)9, whereas high Cronbach’s alpha’s indicate redundancy of one or more items (α 
> 0.90)9,11. Cronbach’s alpha’s have been calculated for each (sub)scale separately of 
the MDADI and the DHI (see Table 3). All Cronbach’s alpha’s are between .76 and .94, 
thus indicating good internal consistency, although some redundancy may be present. 
Considering the outcome of the factor analyses without any obvious homogeneous 
(sub)scales detected as well as the adequate Cronbach’s alpha’s per (sub)scales, the 
internal consistency of both questionnaires might be described as yet unclear10.
The associations among the four patient administered questionnaires plus the FOIS, 
and among the subscales per instrument were determined by nonparametric 
Spearman’s correlation coefficients as well (Table 4 and 5). For the correlations 
coefficients (R), a minimum value for a strong correlation was set at 0.7 and above12,13,14. 
Correlation coefficients between 0.3 and 0.7 were considered to be a substantial 
correlation only and R-values < 0.3 were considered to be a weak correlation. Negative 
correlations are expected as all questionnaires but the DHI, associate lower scores 
Table 3. Cronbach’s alpha per (sub)scale of the MD Anderson Dysphagia Inventory (MDADI) and the Deglutition 
Handicap Index (DHI).
Quality of Life Scale Cronbach’s alpha
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with more severely impaired quality of life or restricted functional oral intake. 
Correlations between the quality of life instruments and the functional feeding status 
proved rather low (-.013≤R≤.53). Construct validity could be determined by comparing 
(sub)scales from the MDADI and the DHI that were supposed to measure the same 
concept. Associations between similar subscales from both questionnaires as well as 
both total scores demonstrated whether or not they defined the same target construct 
(convergent validity). Correlation coefficients between both emotional, functional 
and physical subscales from the MDADI and the DHI were, respectively, -.93, -.65, and 
-.62. The correlations between the Dysphagia Severity Scale and both total scores from 
the MDADI and the DHI were rather low (respectively, .45 and -.52), whereas the 
correlation between both total scores of the MDADI and the DHI was strong (R=-.87). 
The mean correlation coefficients between the subscales of the MDADI and between 
the subscales of the DHI, were respectively, .80 (.66≤R≤.82) and .60 (.54≤R≤.66). 
When considering the Swal-Qol as the reference standard or gold standard, the extent 
to which the MDADI and the DHI agreed or correlated with the Swal-Qol could be 
defined as the questionnaires’ criterion validity. Table 5 presents the associations 
among the Swal-Qol versus the MDADI, the DHI, the Dysphagia Severity Index and the 
FOIS (nonparametric Spearman’s correlation coefficients). The mean correlation 
coefficients between subscales from the Swal-Qol versus the total score of the MDADI, 
the total score of the DHI, and the Dysphagia Severity Scale were, respectively, .67 
(.39≤R≤.86), -.61 (-.38≤R≤-.80), and .36 (.30≤R≤.73). Next, based on the authors’ clinical 
experience, subscales that were considered to be of lesser importance to oropharyngeal 
dysphagia, were excluded by mutual consensus. Thus, when excluding the subscales 
Fear, Sleep, Fatigue, and Communication, the mean correlation coefficients were, 
respectively, .76 (.62≤R≤.86), -.71 (-.60≤R≤-.80), and .42 (.31≤R≤.73). According to Terwee 
et al. (2007), the correlation with the reference standard needs to be at least .70. Only 
after having excluded the less relevant subscales of the Swal-Qol, the MDADI as well 
as the DHI show satisfactory associations with the reference standard.
DISCUSSION & CONCLUSIONS
In this study the psychometric characteristics have been determined for the MDADI as 
well as the DHI. The Dysphagia Severity Scale was introduced to reveal any advantages 
or disadvantages of using elaborated questionnaires compared to a simple visual 
analogue scale, while the Swal-Qol was considered the refernce or gold standard. None 
of the quality of life questionnaires showed any floor of ceiling effects. The test retest 
reliability of the MDADI and the Dysphagia Severity Scale proved to be good. However, 
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because of too many missing data in case of the DHI, the test retest reliability of the 
DHI could not be determined even though the intraclass correlation coefficients were 
rather high. The internal consistency using Cronbach’s alpha’s seemed to be good. 
However, when applying confirmatory factor analysis, the underlying constructs as 
defined by the subscales per questionnaire could not be distinguished. Probably, 
because of unclear constructs, only both emotional subscales were strongly correlated, 
whereas the associations between the other corresponding subscales were just 
moderate. Overall, the Dysphagia Severity Scale, showed rather low correlations with 
the other three questionnaires. It seemed that a detailed questionnaire could not be 
replaced by a single one item scale, quantifying the severity of the swallowing disorder. 
The concepts being measured proved to be different. When considering the criterion 
validity, the MDADI as well as the DHI showed satisfactory associations with the Swal-
Qol after having removed its less relevant subscales.
In conclusion, when considering the validity and reliability of the Dutch version of the 
MDADI and the DHI, not all psychometric characteristics have been met sufficiently. In 
general, the importance of determining these psychometric characteristics and of 
objectifying concepts such as validity and reliability, must be stressed when developing 
a questionnaire. If a questionnaire’s characteristics prove to be poor, the study results 
cannot be interpreted correctly nor can any clinical relevance be determined. Therefore, 
it is recommended that in future outcome studies, only quality of life questionnaires 
will be used that show sufficiently good psychometric characteristics.
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Oropharyngeal dysphagia (OD) has a major influence on health in general and health-
related quality of life (HR-QoL) in particular. The gold standard assessments for OD, 
especially for aspiration in OD, are fiberoptic endoscopic evaluation of swallowing 
(FEES) and videofluoroscopy (VFS), but not all patients have access to such procedures. 
Therefore, the current study built a prediction model to forecast aspiration in patients 
with OD on the basis of common self-evaluation questionnaires and oral intake status. 
Methods
A consecutive series of 111 patients with confirmed diagnosis of OD was measured 
according to a standardised protocol using the following tools: the Swallowing Quality 
of Life Questionnaire (SWAL-QOL), the Dysphagia Handicap Index (DHI), two self-report 
visual analogue scales which measure the severity and the impairment of the 
swallowing problem on everyday social life as experienced by the patient, the Eating 
Assessment Tool 10 (EAT-10), the Functional Oral Intake Scale (FOIS) and subsequently 
FEES (the gold standard). Penalised logistic regression was carried out to predict 
aspiration. The performance of the resulting models was evaluated by constructing 
receiver operating characteristics (ROC) curves and computing areas under the curve 
(AUC).
Results
The final model showed an AUC of 0.92, indicating excellent performance.
Conclusion
This study shows that it may be possible to accurately predict aspiration in 
oropharyngeal dysphagia by a non-invasive and non-instrumental assessment protocol 
including oral intake status and self-report questionnaires on functional health status 
and HR-QoL.




Oropharyngeal dysphagia (OD) has a major influence on health in general and notably 
on health-related quality of life (HR-QoL)[1-3]. OD is known to negatively influence 
social life; patients may no longer enjoy eating and drinking, and may avoid social 
activities[1]. In turn, OD can cause dehydration and malnutrition[2, 4]. Moreover, OD 
has economic consequences; Bonilha et al.[5] calculated that the costs for OD in stroke 
patients were $ 4510 per patient per year. For all of these reasons, detecting OD and 
optimising its care is increasingly important. 
Aspiration or silent aspiration in severe OD can cause aspiration pneumonia and, when 
accompanied by malnutrition and dehydration, can lead to hospitalization, IC admission 
or even death[2, 4]. The gold standards for detecting aspiration and silent aspiration 
are videofluoroscopic (VFS) and fiberoptic endoscopic evaluation of swallowing (FEES). 
While both have a high sensitivity and specificity[6], they are invasive, may be 
burdensome for the patient and are expensive. Moreover, these gold standards are 
not generally available in clinical settings such as a nursing home or general practice. 
Screening for OD can be performed in various ways such as by trial swallows using 
water or substances with different viscosities, by oxygen desaturation or by cough 
elicitation[7, 8]. Screening should be sufficiently sensitive and specific but also easy to 
administer without extensive training[7]. When patients fail the screening, further 
assessment of OD is recommended. Numerous assessments are available to evaluate 
OD in further detail. Each one is focussed on certain domains such as functional health 
status (FHS), health-related quality of life (HR-QoL) or oral intake. Two commonly used 
FHS questionnaires are the Eating Assessment Tool (EAT-10)[9] and the Sydney Swallow 
Questionnaire (SSQ)[10], and a common HR-QoL questionnaire is the Swallowing 
Quality of Life questionnaire (SWAL-QOL)[11].  Self-evaluation questionnaires such as 
the Dysphagia Handicap Index (DHI)[12] include items on both HR-QoL and FHS. Some 
measures have several subscales and over 40 items (e.g., SWAL-QOL), whereas others 
consist of a single visual analogue scale on swallowing function[13] or a single ordinal 
scale on oral intake (e.g., Functional Oral Intake Scale or FOIS)[14]. 
The presence of aspiration is the most critical clinical sign in patients with OD. However, 
the literature[15, 16] reveals a moderate to low correlation between self-evaluation 
questionnaires and aspiration as determined by FEES or VFS. Also, oral intake as 
assessed by the FOIS shows weak correlations with aspiration[14]. 
Predictive modelling entails developing a mathematical tool that generates an accurate 
prediction[17]. Several studies on dysphagia have used predictive modelling to forecast 
swallowing problems based on various criteria: for example, dosimetric parameters 
in radiotherapy[18, 19], tumour size and location[19], VFS parameters[20] or cervical 
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auscultation[21]. The predicted outcome of the models ranged from radiotherapy-
induced dysphagia[18, 19] to persistent dysphagia after stroke[20] and presence of 
aspiration[21]. The predicted outcome of most studies was dysphagia, though not 
differentiating between dysphagia with or without aspiration. To the best of our 
knowledge, no models thus far have used individual or combined self-evaluation 
questionnaires on FHS and/or HR-QoL in OD for predicting aspiration. 
Clinicians often employ patient self-evaluation in daily clinical practice and recognise 
the importance of early detection of aspiration when working with patients with OD. 
With their co-operation, predictive modelling using questionnaires as predictors and 
aspiration as the outcome becomes an option. The possibility of collaboration led to 
the design for the current study: the purpose was to build a predictive model that could 
forecast aspiration in patients with OD using oral intake status and commonly used 
self-evaluation questionnaires on FHS and HR-QoL.
METHODS
Patients
The study included a consecutive series of patients with OD who visited the outpatient 
clinic of the department of Otorhinolaryngology and Head and Neck Surgery of the 
Leiden University Medical Centre. Patients were included if they (1) were at least 18 
years old and (2) were not suffering from severe cognitive problems. All had a confirmed 
diagnosis of OD based on FEES examination by an experienced ENT specialist or 
speech-language pathologist (SLP). This study was approved by the local Medical Ethical 
Committee.
Measures
As part of standard care at the outpatient clinic of the department of Otorhinolaryngology 
and Head and Neck Surgery, all patients completed several self-evaluation 
questionnaires during the week prior to their FEES exam. The following standardised 
protocols were used (listed in order of administration).
1.  The SWAL-QOL[11, 22, 23] is a 44-item questionnaire on HR-QoL. It is considered 
to be the gold standard for measuring HR-QoL in OD[24]. The SWAL-QOL consists 
of ten subscales (Burden, Eating duration, Eating desire, Food selection, 
Communication, Fear, Mental health, Social functioning, Fatigue and Sleep) and 
one symptom scale (14 items, among which coughing, choking, gagging and 
drooling)[25]. The minimum and maximum scores on each subscale range from 
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0 to 100: not impaired to extremely impaired HR-QoL, respectively.
2.  The DHI[12] measures FHS as well as HR-QoL. This 25-item questionnaire concerns 
the effect of OD on Physical (9 items), Functional (9 items) and Emotional (7 items) 
aspects of patients’ lives. Each item is scored as 0, 2 or 4, with higher scores 
meaning more severe disability. The total score ranges from 0 to 100. The DHI has 
one additional question about the severity of a patient’s swallowing problem 
ranging from 1-7 (Severity question: 1 normal,  7 severe problem). 
3. Each of two concise self-report 100-mm Visual Analogue Scales (VAS)[13] measures 
a certain aspect of swallowing. One concerns the severity of the swallowing 
problem as experienced by the patient (Severity: FHS), whereas the other measures 
the perceived impact of the swallowing problem on everyday social life (Impairment: 
HR-QoL). Higher scores indicate greater impairment (range 0 - 100).
4.  The EAT-10[9] is a short 10-item self-administered questionnaire[8]. Although 
predominantly regarding FHS, it also includes some HR-QoL items [26]. Each one 
is rated on a five-point scale (0-4); the summed score ranges from 0 to 40 (higher 
scores are more abnormal). A sum of ≥ 2[27] or ≥3[9] is considered abnormal.
6.  The Functional Oral Intake Scale (FOIS)[14] registers actual oral intake. The scores 
range from 1 (nothing by mouth) to 7 (total oral diet with no restrictions). During 
a patient’s visit to the outpatient clinic, the FOIS was completed by the clinician.
Subsequently, FEES was performed according to a standardised protocol[28]. Patients 
were offered three swallow trials of three different consistencies (nine trials maximum): 
methylene blue dyed water (thin) or applesauce (thick) in portions of 10 mL and three 
bite-sized crackers with a fixed weight of 3.3 g (solid). In the event of aspiration, the 
trial of that particular consistency was stopped. FEES examinations were performed 
with a XION chip-on-the-tip flexible nasendoscope (Berlin, Germany). Results were 
recorded with RVC Clinical Assistant (Baarn, the Netherlands), a medical archive and 
image viewer. Recordings were rated by consensus among two SLPs using the 
Penetration Aspiration Scale (PAS)[29]. FEES results were dichotomised into no 
aspiration (PAS score 1-3) or aspiration (PAS scores 4-8)[30]. If the patient aspirated 
during any of the (maximum of) nine trials with any of the three consistencies, he or 
she was considered an aspirator in this study. All patients were categorised either as 
aspirating or not. 
Statistical analysis
Logistic regression was used to predict the outcome (dichotomous variable: aspiration 
present/absent). Model performance was evaluated by constructing receiver operating 
characteristics (ROC) curves and computing areas under the curve (AUC). In order to 
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objectively evaluate whether individual questionnaire items contributed to prediction, 
a penalised version of logistic regression was used on all items. To that end, a variant 
of the LASSO regression was applied, namely the elastic net. LASSO allows to 
simultaneously perform model selection and estimation, whereby variables not 
contributing to prediction are removed from the model. A penalty parameter 
determines how many variables are retained. This parameter is chosen automatically 
by a cross-validation procedure. AUC and glmnet packages in R version 3.4.0 were used 
for all analyses[31]. 
RESULTS
Patient characteristics
One-hundred-eleven patients were included from June 2014 till November 2015 (Table 
1). Sixty-seven subjects (60%) were male with a median age of 65 years (IQR 58-71) 
compared to 44 (40%) female subjects with a median age of 67 years (IQR 52-74). 
Medical diagnoses included head and neck cancer (36%) and neurological disorders 
(37%) such as stroke, Parkinson’s disease, multiple sclerosis and myotonic dystrophy. 
The remaining patients (27%) had diagnoses like general weakness due to other 
diseases, cricopharyngeal muscle hypertrophia or epiglottitis. The median FOIS score 
for the total group was 6 (IQR 4-7), so most patients had an oral intake with some 
restrictions.
Descriptive statistics
Table 2 displays the descriptive statistics for the SWAL-QOL, DHI, VAS and EAT-10. The 
median scores on the SWAL-QOL subscales were Burden 38 (IQR 13-75), Eating duration 
38 (IQR 0-75), Eating desire 67 (IQR 33-92), Food selection 63 (IQR 25-75), Communication 
75 (IQR 38-88), Fear 75 (IQR 56-94), Mental health 55 (IQR 35-85), Social functioning 55 
(IQR 30-85), Fatigue 58 (IQR 33-75) and Sleep 75 (IQR 38-88). The median SWAL-QOL 
symptom score was 61 (IQR 46-71). The median DHI total score was 48 (IQR 28-64) and 
the additional DHI Severity question showed a median of 5 (IQR 4-6). The median VAS 
scores on Severity and Impairment were 51 (IQR 30-80) and 55 (IQR 30-85) mm, 
respectively. The EAT-10 had a median score of 15 (IQR 8-23). 
FEES showed no aspiration in any of the nine trials using three different viscosities 
(thin, thick, solid consistency) in 90 (81%) patients. A group of 21 (19%) patients 
aspirated on at least one swallow trial.




To build prediction models, first two sets of variables (A and B) were specified a-priori 
(Table 3). In a second, exploratory step, automatic variable selection was used to choose 
the prediction model. 
Pre-specified variables
The first set of variables (A) in the logistic regression model was selected on the basis 
of the literature and clinical experience. Six subscales of the SWAL-QOL (HR-QoL) 
were considered of lesser importance to oropharyngeal dysphagia and, therefore, 
excluded: Communication, Fear, Mental health, Social functioning, Fatigue and 
Sleep[32]. The remaining subscales, namely Burden, Food selection, Eating duration 
and Eating desire, and the Symptom scale of the SWAL-QOL were included, as were 
the DHI total subscale scores (Functional, Physical and Emotional subscales) and both 
VAS scales on swallowing (Severity and Impairment)[13]. As coughing is considered 
a clinically relevant symptom of aspiration, item 9 of the EAT-10 (I cough when I eat) 
was also listed [33]. Lastly, the FOIS was added to include information about oral 
intake. This prediction model yielded an AUC of 0.862.
The second set (B) included fewer variables: the subscale Food selection of the SWAL-
QOL, the DHI subscales (Functional, Physical and Emotional), item 9 of the EAT-10 and 
the FOIS. Both VAS scales and the remaining SWAL-QOL subscales were excluded. This 
reduced model obtained an AUC of 0.852.
The first analysis using set A identified a non-linear association between the gold 
standard and the Symptom scale of the SWAL-QOL, which led to the inclusion of a 
quadratic term for the Symptom scale score. Based on this second model, an AUC of 
Table 1. Subject characteristics
Total group 111
Number of subjects [n (%)] Male (%) 67 (60)
Female (%) 44 (40)
Age in years [Med (IQR)] Total group 66 (56-72)
Male 65 (58-71)
Female 67 (52-74)
Medical diagnosis [n (%)] Head and neck cancer 40 (36)
Neurological disorder 41 (37)
Other 30 (27)
FOIS1 [Med (IQR)] 6 (4-7)
1 Range 1 – 7: ‘Nothing by mouth’ to ‘Total oral diet with no restrictions’.
2001816 binnenwerk_Bastiaan Heijnen.indd   111 20-08-18   08:59
CHAPTER 6
112
0.874 was found. Because the Symptom scale score was not included in set B, this 
prediction model remained unchanged.
Score X =
18.6591708 + (0.0007031* SWAL-QOL Burden) + (0.0326739* SWAL-QOL Food Selection) 
– (0.0219832* SWAL-QOL Eat duration) + (0.0081344* SWAL-QOL Eat desire) – 
(0.2093808*SWAL-QOL Symptom) + (0.0020425*SWAL-QOL Symptom Squared) + 
[(0.6740265*DHI item 1p score 2) + (3.5526187* DHI item 1p score 4)] – [(19.2522260*DHI 
Severity Question score 2) – (36.8925068*DHI Severity Question score 3) –(19.3098857* 
DHI Severity Question score 4) – (19.9454640* DHI Severity Question score 5) – 
(18.4990410*DHI Severity Question score 6) – (15.9065488*DHI Severity Question score 
7)] – (0.0363491* VAS Severity) + (0.0428708* VAS Impairment) + [(4.6092903*EAT10 item 
9 score 1) + (4.3063001*EAT10 item 9 score 2) + (3.6040778* EAT10 item 9 score 3) + 
(1.8982514*EAT10 item 9 score 4)] – (0.4016869*FOIS)
The inverse logistic function of the final score X indicates the chance of aspiration:
Paspiration f(x) = 1/(1 + exp(-x))
Automatic variable selection
The first penalised logistic regression included all available variables. Based on this 
regression, certain variables were added to sets A (model 2) and B (model 1). For the 
first set of variables (A), the DHI additional question on severity (Severity question) and 
the DHI item 1p (‘I cough when I drink’) were added. For the second set (B), the squared 
Symptom scale score was added in addition to the two DHI items (Severity question 
and item 1p). This yielded AUCs of 0.922 for set A and 0.915 for set B.
Table 3 provides an overview of the included variables and the results per prediction 
model by showing per item the odds ratio, 95% confidence interval and p-value. Figure 
1a-e presents ROC figures and AUC outcomes per model. The following formula predicts 
the presence of aspiration in an individual subject based on the penalised logistic 
regression model (model 3) using the first set of variables A with an AUC of 0.922: 
Thus, to determine the chance of aspiration in an individual with OD, the following 
scores need to be entered in the formula:
-  SWAL-QOL: subscales Burden, Food Selection, Eat Duration, Eat Desire and Symptom 
score (ranging from 0 to 100);
-  DHI: Item 1p and Severity question. In the formula variables are included per score 
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for item 1p (score 0, 2 or 4) and for Severity question (score 2 to 7; not 1). These 
variables include binary numbers (present = 1; absent = 0); For example, if item 1p 
is scored 2, the section of the formula relating to item 1p is completed as follows: 
(0.6740265*1) + (3.5526187* 0); 
-  VAS: Severity and Impairment (score 0-100);
-  EAT10: item 9. In the formula variables are included per score for item 9 (score 1, 2, 
3 or 4). These variables are expressed as binary numbers (present = 1; absent = 0); 
-  FOIS (score 0-7).
Next, to determine the chance of aspiration, the inverse logistic function of the final 
score X needs to be calculated.
Table 2. Descriptive analysis of patient self-evaluation questionnaires (n=111): SWAL-QOL, Dysphagia Handicap 
Index (DHI), Visual Analogue Scales (VAS), EAT-10. 
Questionnaire1 (Sub)scale Range scale Median (IQR) 
SWAL-QOL Burden 0-100 38 (13-75)
Eating duration 0-100 38 (0-75)
Eating desire 0-100 67 (33-92)
Food selection 0-100 63 (25-75)
Communication 0-100 75 (38-88)
Fear 0-100 75 (56-94
Mental health 0-100 55 (35-85)
Social functioning 0-100 55 (30-85)
Fatigue 0-100 58 (33-75)
Sleep 0-100 75 (38-88)
Symptom score 0-100 61 (46-71)
DHI Physical 0-36 16 (10-22)
Functional 0-36 20 (10-28)
Emotional 0-28 10 (4-18)
Total score 0-100 48 (28-64)
Severity question 1-7 5 (4-6)
VAS Severity (FHS) 0-100 51 (30-80)
Impairment (HR-QoL) 0-100 55 (30-85)
EAT-10 Total score 0-40 15 (8-23)
1 Higher scores indicate higher degree of disability.
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Figure 1a. ROC Model 1 Variable set (A) 
included the following variables: 
SWAL-QOL subscales Burden, Food 
selection, Eat duration, Eat desire and 
Symptom scale, DHI subscales 
(Functional, Physical and Emotional), 
VAS scales (Severity and Impairment), 
EAT-10 item 9 (‘I cough when I eat’) 
and FOIS. AUC 0.862.
Figure 1c. ROC Model 2 Variable set (A), 
included the following variables: 
SWAL-QOL subscales Burden, Food 
selection, Eat duration, Eat desire, 
Symptom scale and Symptom scale 
squared, DHI subscales (Functional, 
Physical and Emotional), VAS scales 
(Severity and Impairment), EAT-10 
item 9 (‘I cough when I eat’) and FOIS. 
AUC 0.874
Figure 1b. ROC Model 1 Variable set 
(B). Reduced model to SWAL-QOL 
Food Selection, DHI subscales 
(Functional, Physical and Emotional), 
EAT-10 item 9 (‘I cough when I eat’) 
and FOIS. AUC 0.852.




The purpose of this study was to build a prediction model for aspiration in patients 
with OD using common self-evaluation questionnaires and patients’ oral intake status. 
Logistic regression modelling is the preferred method for this[34]. Herein, the number 
of parameters tested determines the size of the study population needed[35]. Both 
clinical experience and prior knowledge from the literature may be used to limit the 
number of predictors in such models. The variable selection was based on these 
assumptions. Good accuracy was found [36], i.e. AUC of 0.86 and 0.85 for variable sets 
A and B, respectively. Subsequently, LASSO regression showed excellent accuracy, i.e. 
AUC of 0.92 for selection of variables from both sets A and B. The resulting formula 
may be used in the future as a guide to predict aspiration in patients with OD. 
This study has some limitations. Firstly, the subjects had high FOIS scores, i.e. no 
functional impairments in oral intake or only mild impairments. This may have 
influenced our findings and the generalisability of the results. In view of that possibility, 
Figure 1e. ROC Model 3 Variable set (B) 
included the following variables: 
SWAL-QOL subscales Food selection 
and the Symptom scale squared, DHI 
subscales (Functional, Physical and 
Emotional), DHI item 1p (‘I cough when 
I drink’), DHI Severity question, EAT-10 
item 9 (‘I cough when I eat’) and FOIS. 
AUC 0.915
Figure 1d. ROC Model 3 Variable set (A) 
included the following variables: 
SWAL-QOL subscales Burden, Food 
selection, Eat duration, Eat desire, 
Symptom scale and Symptom scale 
squared, DHI item 1p (‘I cough when I 
drink’), DHI Severity Question, VAS 
scales (Severity and Impairment), EAT-
10 item 9 (‘I cough when I eat’) and 
FOIS. AUC 0.922
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a consecutive series of patients was included to avoid selection bias. As such, our 
population forms a representative sample of persons visiting an outpatient clinic for 
dysphagia in an academic hospital setting. Secondly, only details on the LASSO 
regression model using the set of variables A are presented here. However, as the 
AUCs were almost equal for both sets (A and B) when using LASSO regression modelling, 
the option of using set B in daily clinics might be considered as well. Clinicians may 
prefer to use DHI subscales rather than adding the SWAL-QoL subscales and VAS scales 
on Severity and Impairment. Future studies may consider such clinical preferences 
when building regression models. Thirdly, external validation of the findings in another 
group of patients with OD was not performed. Nonetheless, all predictive models 
showed good to excellent accuracy with all AUC ≥ 0.85 and AUC exceeding 0.92 when 
using LASSO regression. Even though no great differences are expected when other 
groups of patients with OD are included, it may be interesting to compare the current 
results with those from future studies in other populations with OD. Casting the net 
wider might reveal similarities or discrepancies in study outcomes; to what degree our 
predictive model can be generalised to other patient populations remains to be 
evaluated in follow-up research. Our model can be considered a first step towards the 
assessment of aspiration risk in patients with OD using oral intake and self-report 
questionnaires only. The high accuracy of the final prediction model seems to make 
this a very promising avenue. 
These findings are relevant for clinical practice and underscore the importance of self-
reported evaluations in the clinical assessment of patients with OD. Until now, these 
questionnaires were used to measure concepts such as FHS and HR-QoL. They were 
not used for decision-making; specifically, they were not used to determine whether 
a patient with dysphagia was at risk for aspiration. The current study suggests that in 
the absence of gold standard measures, an accurate risk assessment can be performed 
on the grounds of combined oral intake and self-reported FHS and HR-QoL. Possibly, 
future studies may address the usefulness of the current assessment protocol in clinical 
settings such as nursing homes or general practices where access to VFS or FEES may 
still be limited, in contrast to the widespread availability in tertiary centres nowadays. 
Furthermore, the use of a non-instrumental assessment protocol to identify aspiration 
in patients with OD may reduce costs in healthcare.
CONCLUSIONS
This study shows that aspiration in patients with OD may be predicted by a cost-
effective, simple and non-invasive assessment protocol including oral intake status 
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and patient self-evaluation questionnaires on FHS and HR-QoL. A predictive model was 
built using data from a consecutive series of patients at an outpatient clinic of a tertiary 
care centre. This model may be used to predict aspiration in patients with OD. 
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OD is the disturbance in the process of transporting solids or liquids from the mouth 
to the esophagus. OD can cause major complications such as dehydration, malnutrition, 
aspiration pneumonia, and even death. Because OD is often a secondary expression 
of another primary cause, it is underdiagnosed, with consequences such as aspiration 
pneumonia and negative effects on FHS and HRQoL. 
The effects of OD may impact domains such as a patient’s health or FHS, HRQoL, and 
social functioning. Also the burden it places on the caregiver should not be 
underestimated. 
Over the last two decades, there has been a huge increase in publications on OD, as 
objectified by electronic database searches. Recent studies on the reliability and validity 
of commonly used instruments show insufficient psychometric robustness. Despite 
the availability of FEES and VFS as the gold standard for the assessment of OD, in 
practice the screening and measuring of HRQoL and FHS show room for improvement. 
An analysis of studies reporting on OD revealed that outcomes are often not 
comparable due to substantial differences in measurement techniques and study 
designs. Despite the increase in publications and attempts to improve OD care, the 
low quality of the study designs and the use of measurement instruments with 
insufficient psychometric properties hamper the comparison of results between 
studies. When the tools are insufficiently robust, the interpretation of outcomes in all 
published studies using these instruments remains unclear and possibly flawed. 
To improve their robustness, the questionnaires should be redesigned and re-
evaluated. Until then, investigators should use only the best available ones, basing 
their choice on the psychometric properties of the tools. Despite known shortcomings, 
the questionnaires used in this thesis were the best ones available at the time they 
were administered. 
The scope of this thesis spanned several issues in the measurement and evaluation 
of OD. The screening, assessment, and treatment effect for OD have been covered, 
with a special emphasis on patient self-evaluation. The need for further research is, 
however, evident. 
When reviewing the literature on a specific clinical diagnosis, such as HNC, it was 
observed that the attention traditionally given to a primary disease or illness and its 
treatment, both in general practice and in research settings, has shifted in the course 
of the decade toward functional outcomes. Although reports on functional outcomes 
have appeared more frequently, their usability leaves much to be desired. One reason 
is that assessing functional outcomes is seldom the first priority of these studies but 
rather a secondary aspect. Another reason is that the outcomes are often uncomparable 
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due to methodological, measurement, and evaluation differences between the studies. 
Consequently, the amount of meta-data being generated is insufficient for meta-
analysis, which makes it impossible to obtain outcomes for large cohorts or draw 
conclusions for functional outcomes of specific interventions. In line with the previous 
shortcomings the effects of speech language therapy, among others, would need to 
be studied and the results of those studies should be carefully reported.
In light of the literature review in chapter 2 and the gaps mentioned above, there is a 
clear need for consensus on methods and minimum requirements for research and 
reporting on functional outcomes. In particular, the following needs should be 
addressed: 
-  Consensus on which measurement or evaluation technique is appropriate for each 
functional outcome: e.g. voice, speech, swallowing, trismus, and HRQoL. 
-  Consensus on measurement moments, with a minimal requirement of measuring 
pre-therapy and preferably long-term post-therapy.
When shifting the focus of attention from HNC to a chronic disease, for instance 
Parkinson’s disease (PD), with a wide variety of functional impairments, a review of the 
literature reveals an extensive range of treatment results. In contrast, there are fewer 
reports on the outcomes of swallowing therapy. Since dysphagia in PD can cause major 
complications, it would be important to evaluate existing, new, and additional therapies. 
In this thesis it was shown, in chapter 3, how to systematically evaluate the effect of a 
new treatment modality for dysphagia in PD. In a randomized clinical trial both pre- and 
post-therapy outcomes were taken into account when evaluating the participants’ 
HRQoL and functional outcomes with reference to the dietary intake. Although all 
groups showed lasting improvement in HRQoL and severity scores after therapy, no 
correlation was found between those scores and dietary intake. 
A large share of diagnostics in dysphagia care consists of determining whether a patient 
is at risk for dysphagia before deciding to subject that individual to further assessment. 
Although many screening tools are available to identify patients who need further 
dysphagia assessment, there is a need for short, fast, and easy screening options. A 
common starting point is just asking whether a patient has a swallowing complaint 
instead of using a questionnaire or screening instrument. Until now, to the best of our 
knowledge, no research has been done on the value of asking that straightforward 
question. Determining the sensitivity and specificity of a single question could make 
everyday clinical practice more evidence-based. Moreover, a simple technique could 
lead to time and cost savings without disrupting the course of activity or progress in 
the outpatient clinic. As mentioned in chapter 4, further research is necessary to 
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provide additional psychometric data on Functional Health Status (FHS) questionnaires, 
including the single question, and how the resulting information can be combined with 
the results from either fiberoptic endoscopic evaluation of swallowing (FEES) or 
videofluoroscopy (VFS) as the gold standard or reference test. With the knowledge of 
recent studies on the reliability and validity of commonly used instruments this study 
shows that the use of a simple question has also a potential share in screening for OD. 
The advantages of a screening questionnaire versus a screening question should be 
weighed up in order determine the advantages and disadvantages e.g. burden for the 
patient or time consumption. Innovation requires looking at what is already there with 
different eyes. Thus, a single question can be as good as a questionnaire.
From the starting point of screening for dysphagia, it is usual to continue on to further 
assessment. At that point, QoL is considered an important outcome measurement, as 
it objectifies the current health status or therapy effects in patients with OD. Measuring 
HRQoL requires instruments that are reliable and valid, however. To that end this thesis 
assessed two questionnaires, the M.D. Anderson dysphagia inventory and the 
Deglutition Handicap Index, in terms of their reliability and validity. It was shown how 
to evaluate their reliability and validity in a structured and constructive manner in 
chapter 5. 
Not every health professional has access to the gold standard procedures to evaluate 
the presence of aspiration in dysphagia. In most nursing homes, for example, there is 
absence of the equipment to execute FEES or VFS. To avoid unnecessary diagnostic 
procedures, innovative options should be given due consideration. These novel 
techniques should be easy to administer, put less burden on the patient and health 
professional, be reliable, and yield consistent results. In an attempt to fill that need, 
we built a prediction model to forecast aspiration in patients at risk for OD on the basis 
of common self-evaluation questionnaires and oral intake status. Using commonly 
available instruments, it was shown that it is possible to accurately predict aspiration 
in oropharyngeal dysphagia by a non-invasive and non-instrumental assessment 
protocol including oral intake status and self-report questionnaires on FHS and HRQoL. 
The performance of the final model was excellent. On the basis of findings in chapter 
6, we conclude that every health professional can determine, after further evaluation 
of this technique, whether aspiration is present in a patient or not.
2001816 binnenwerk_Bastiaan Heijnen.indd   126 20-08-18   08:59
127
SUMMARY, GENERAL DISCUSSION AND CONCLUSIONS
FUTURE STUDIES
The measurement and evaluation of OD may improve significantly when new FHS and 
HRQoL questionnaires are developed in line with item response theory (IRT) such as 
Rasch analysis. By departing from the classical approach to questionnaire development 
and applying newer methods, the methodological issues that have arisen over the past 
years can be resolved. Consequently, measurement and evaluation would become 
more accurate and informative, thereby improving the care for OD. Second, a more 
uniform way of evaluating OD and its treatment can facilitate quantitative and 
qualitative comparisons, which in turn could lead to better treatment choices and more 
pertinent outcome knowledge. There is still a need to raise awareness of 
underdiagnosed OD as a consequence of other more prominent diseases. Attention 
to comorbidity is warranted not only to manage the health-related consequences and 
their implications for the patient’s FHS or HRQoL but also to reduce the carer’s burden. 
All multi-dimensional aspects of OD should be taken into account when characterizing 
a patient.
With innovations and novel perspectives, new avenues may open to connect applied 
research and evidence-based clinical practice with the field providing dysphagia care. 
The first step in that direction is to make evidence-based methods of diagnosing OD 
more accessible to health professionals with no access to the gold standard. The 
outcomes and recommendations presented in this thesis may give some useful 
guidance for this development.
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Orofaryngeale dysfagie (OD) is een probleem in het proces van het transporteren van 
voeding van de mond naar de oesophagus. OD kan grote gevolgen hebben zoals 
dehydratie, ondervoeding, aspiratie, longontsteking en zelfs overlijden. OD is vaak 
een secundaire uiting van een onderliggend probleem, waardoor het 
ondergediagnosticeerd is, met mogelijk aspiratiepneumonieën, overlijden, negatieve 
gevolgen voor de functionele gezondheidstoestand en gezondheidsgerelateerde 
kwaliteit van leven als gevolg.
OD kan invloed hebben op verschillende aspecten van het leven van de patiënt, zoals 
de algemene gezondheid, functionele gezondheidstoestand, gezondheidsgerelateerde 
kwaliteit van leven en het sociaal functioneren. Ook de belasting voor de mantelzorger 
moet niet onderschat worden.
De laatste twee decennia is er een forse toename van studies naar OD en publicaties 
over OD. Recente studies naar betrouwbaarheid en validiteit van vaak gebruikte 
instrumenten laten onvoldoende kwaliteit zien van de psychometrische kenmerken. 
Ondanks de beschikbaarheid van een gouden standaard voor het onderzoek naar OD, 
laat de dagelijkse praktijk ruimte voor verbetering van het screenen naar OD en het 
meten van gezondheidsgerelateerde kwaliteit van leven en functionele 
gezondheidstoestand middels vragenlijsten.
Een analyse van studies die over OD rapporteren laat resultaten zien die niet goed met 
elkaar te vergelijken zijn. Dit wordt veroorzaakt door substantiële verschillen in 
evaluatietechnieken en studie opzet. Ondanks het stijgende aantal onderzoeken en 
pogingen om de zorg voor OD te verbeteren, maakt de lage methodologische kwaliteit 
van studies, het gebruik van instrumenten met psychometrische kenmerken van 
onvoldoende kwaliteit, de vergelijking van resultaten tussen studies lastig. Het gebruik 
van meetinstrumenten die onvoldoende kwaliteit hebben, heeft grote invloed op de 
interpretatie van resultaten uit deze studies.
Om deze kwaliteit te verbeteren moeten de vragenlijsten opnieuw ontwikkeld en 
gevalideerd worden. Tot dat moment moeten onderzoekers alleen de best beschikbare 
vragenlijsten gebruiken en desbetreffende psychometrische kenmerken in acht nemen. 
De vragenlijsten die gebruikt zijn in deze thesis waren op dat moment, ondanks de 
tekortkomingen, de best beschikbare voor het betreffende doel.
De scope van dit proefschrift omvat verschillende problemen in het meten en evalueren 
van OD. Screening, onderzoek en het effect van de therapie voor OD worden behandeld, 
met de nadruk op zelfevaluatie. De noodzaak naar verder onderzoek is evident.
Kijkend naar een specifiek ziektebeeld zoals hoofd-halskanker, wordt duidelijk dat er 
naast aandacht voor het primaire ziektebeeld en de behandeling ervan zowel in de 
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praktijk als in verschenen publicaties er de laatste tien jaar een verschuiving gaande 
is naar de functionele uitkomsten. Hoewel deze uitkomsten meer gerapporteerd 
worden, laat de bruikbaarheid ervan nog te wensen over. Bijvoorbeeld doordat 
functionele uitkomsten niet de primaire uitkomstmaat van de studie zijn. En als gevolg 
van methodologische, meet- en evaluatie verschillen tussen studies kunnen uitkomsten 
vaak niet met elkaar vergeleken worden. Dit resulteert in een te kleine hoeveelheid 
meta-data waardoor het niet mogelijk is om een meta-analyses uit te voeren.  Hierdoor 
is het niet mogelijk om uitkomsten van grote cohorten te gebruiken en om conclusies 
te trekken voor de functionele uitkomsten van specifieke behandelingen met behulp 
van een meta-analyse.  Daarbij moeten effecten van therapieën, zoals die van logopedie 
onderzocht worden en de uitkomsten dienen nauwkeurig gerapporteerd te worden. 
In het kader van het systematische review in hoofdstuk 2 en de bovengenoemde hiaten 
is het nodig een consensus van minimale vereisten voor het onderzoeken van 
functionele uitkomsten vast te stellen. 
De volgende studie eigenschappen zouden vastgesteld moeten worden: 
- consensus over welke meet- of evaluatietechniek gebruikt dient te worden voor elke 
functionele uitkomst zoals stem, spraak, slikken, trismus en gezondheidsgerelateerde 
kwaliteit van leven.
- aanvullend zou er een consensusbesluit genomen moeten worden over de 
meetmomenten met als minimale vereiste een meting voor de behandeling en bij 
voorkeur een meting (lange termijn) na de behandeling. 
Als de focus verschuift van hoofd- halskanker naar een chronisch ziektebeeld zoals de 
ziekte van Parkinson (ZvP) met een verscheidenheid aan functionele gevolgen is er een 
grote hoeveelheid aan onderzoeksresultaten beschikbaar. Daarentegen zijn er minder 
uitkomsten van therapie voor het slikken beschikbaar. Omdat OD bij patiënten met 
de ZvP grote gevolgen kan hebben is er behoefte aan het evalueren bestaande, nieuwe 
en aanvullende therapieën. Dit proefschrift laat in hoofdstuk 3 zien hoe het effect van 
een nieuwe behandelmodaliteit systematisch geëvalueerd kan worden bij patiënten 
met de ZvP. In een gerandomiseerde klinische trial worden zowel de uitkomsten van 
voor als na de behandeling meegenomen in het bepalen van het effect van de 
behandeling door gebruik te maken van vragenlijsten over de gezondheidsgerelateerde 
kwaliteit van leven en de functionele uitkomsten. Hoewel alle groepen een langdurig 
therapie effect laten zien op het gebied van gezondheidsgerelateerde kwaliteit van 
leven en in de ernst scores na de therapie werd er geen correlatie met de orale intake 
gevonden. 
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Het is belangrijk een patiënt eerst te kunnen screenen op mogelijke OD, alvorens de 
patiënt te onderwerpen aan verder onderzoek. Hoewel er een ruime keuze is aan 
screeningstools om te bepalen welke patiënt verder onderzoek nodig heeft is er 
behoefte aan korte, snelle en makkelijke manieren van screenen. Een veel gebruikte 
techniek is het simpelweg vragen aan de patiënt of hij slikklachten heeft in plaats van 
het gebruiken van een vragenlijst of screeningstool.  Tot nu toe, voor zover we weten, 
is er geen onderzoek gedaan naar de waarde van de uitkomst van een dergelijke vraag. 
In hoofdstuk 4 werd de sensitiviteit en specificiteit van dergelijke technieken bepaald, 
hierdoor wordt de werkwijze in de dagelijkse praktijk meer evidence-based en worden 
tijd- en kostenbesparingen gemaakt zonder het gebruik van buitensporige instrumenten 
die de dagelijkse gang van zaken in de spreekkamer verstoren.
Aanvullende psychometrische gegevens moeten nog verkregen worden om deze 
functionele gezondheidstoestand vragenlijsten, waarbij ook deze anamnestische vraag 
met FEES of VFS (gouden standaard) als referentie test, geëvalueerd wordt. Met de 
huidige kennis van betrouwbaarheid en validiteit van vaak gebruikte vragenlijsten laat 
deze studie zien dat een simpele vraag een potentieel aandeel kan hebben in het 
screenen naar OD. De voordelen van een screenende vragenlijst of één screenings 
vraag moeten tegen elkaar afgewogen worden wat betreft de voor- en nadelen, zoals 
de belasting voor de patiënt of de hoeveel tijd die het gebruik van een instrument kost. 
Innovatie vraagt hier om beschikbare middelen met andere ogen te bekijken. 
Concluderend, een enkele vraag kan net zo informatief zijn als een lijst met vragen. 
Screening wordt vaak logisch opgevolgd door verder onderzoek. Kwaliteit van leven 
wordt beschouwd als een belangrijke uitkomstmaat in het objectiveren van de huidige 
gezondheidstoestand of therapie-effecten bij patiënten met OD. Het meten van 
gezondheidsgerelateerde kwaliteit van leven moet uitgevoerd worden met betrouwbare 
en gevalideerde instrumenten. Twee vragenlijsten, de M.D. Anderson dysphagia 
inventory en de Deglutition Handicap Index, zijn geëvalueerd op betrouwbaarheid en 
validiteit in dit proefschrift. Hoofdstuk 5 laat zien hoe een vragenlijst op een structurele 
en constructieve manier geëvalueerd kan worden.
Niet iedere hulpverlener die met OD te maken heeft, heeft toegang tot de gouden 
standaard om de aanwezigheid van aspiratie te onderzoeken. Bijvoorbeeld in een 
verpleeghuis zijn meestal geen faciliteiten voor het uitvoeren van een FEES of een VFS. 
Om onnodige diagnostiek te voorkomen moeten innovatieve opties overwogen en 
onderzocht worden. Deze opties dienen makkelijk in het gebruik te zijn, niet belastend 
voor de patiënt en hulpverlener en dienen daarnaast betrouwbaar en consistent te 
zijn. In dat kader is er een voorspellend model gebouwd om de aanwezigheid van 
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aspiratie te voorspellen bij patiënten met het risico op OD op basis van gebruikelijke 
zelfevaluatie vragenlijsten en de huidige orale intake.  Met deze instrumenten is het 
mogelijk om accuraat de aanwezigheid van aspiratie te voorspellen door gebruik te 
maken van een niet invasief, niet instrument gebonden onderzoeksprotocol. Het 
uiteindelijke model heeft een excellente prestatie. Met de bevindingen in hoofdstuk 
6, kan elke gezondheidsprofessional, na verdere evaluatie van deze techniek, snel, 
makkelijk en zeker bepalen of een patiënt aspireert of niet.
TOEKOMSTIGE STUDIES
Onderzoek en evaluatie van OD zal waarschijnlijk significant verbeteren wanneer er 
nieuwe functionele gezondheidstoestand en kwaliteit van leven vragenlijsten ontwikkeld 
worden die gebruik maken van de item response theory (IRT) zoals Rasch analyse. Door 
afscheid te nemen van de klassieke vragenlijstontwikkeling en nieuwe 
ontwikkelmethodes toe te passen, zullen de methodologische problemen die de laatste 
jaren aan het licht zijn gekomen worden opgelost. Dit zal als gevolg hebben dat 
onderzoek en evaluatie van OD meer accuraat en informatief worden. Hiermee zal 
tevens de zorg voor OD verbeterd worden. Daarbij is er een meer uniforme werkwijze 
in de evaluatie van OD nodig om zo kwantitatieve en kwalitatieve vergelijking te kunnen 
maken tussen studies. Dit zal leiden tot betere behandelkeuzes en zekerdere resultaten. 
Er is nog steeds behoefte aan een grotere alertheid op ondergediagnosticeerde OD, 
als consequentie van andere, meer prominente, ziektebeelden. Aandacht voor 
comorbiditeit is nodig om de gevolgen voor de gezondheidsgerelateerde consequenties 
te reguleren en om de belasting van de mantelzorgers te verminderen. OD moet 
mulidimensioneel in kaart gebracht worden tijdens de zorg voor patiënten met 
slikproblemen.
Vernieuwingen en nieuwe perspectieven zullen nieuwe mogelijkheden creëren om 
toegepast onderzoek en evidence-based patiëntenzorg met elkaar te verbinden. De 
eerste stap is het toegankelijk maken van methoden voor het diagnosticeren van OD 
zonder de beschikking te hebben over de gouden standaard. De uitkomsten en 
aanbevelingen uit dit proefschrift kunnen voor deze ontwikkeling de eerste stap zijn.
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3DCRT Three dimensional Conformal Radiotherapy
ASHA American Speech-Language Hearing Association
AUC Area Under the Curve
BMI Body Mass Index
COSMIN  Consensus-based Standards for the Selection of Health 
Measurement Instruments
CRT Chemoradiotherapy
CTCAE  Common Terminology Criteria for Adverse Events
D Digestive tract  
DHI Deglutition Handicap Index 
 Dysphagia Handicap Index
DSS  Dysphagia Severity Scale
EAT-10  Eating Assessment Tool-10 
EBP Evidence-Based Practice 
ECOG Eastern Cooperative Oncology Group
ENT Ear, Nose and Throat 
EORTC The European Organization for Research and Treatment of 
Cancer
EORTC QLQ-C30  European Organization for Research and Treatment of Cancer 
Quality of Life Questionnaire
EORTC QLQ-H&N35  European Organization for Research and Treatment of Cancer 
Quality of Life Questionnaire module Head and Neck cancer
FACT-HN Functional Assessment of Cancer Therapy-Head and Neck
FEES Fiberoptic Endoscopic Evaluation of Swallowing
FHS Functional Health Status
FOIS Functional Oral Intake Scale
GRBAS Grade, Roughness, Breathiness, Asthenicity, Strain scale
HNC Head and Neck Cancer
HNCI Head and Neck Cancer Inventory
HNRQ Head and Neck Radiotherapy Questionnaire
HNQoL Head and Neck quality of life
H&Y scale    Hoehn and Yahr scale
HR-PRO Health-Related Patient-Reported Outcomes
HRQoL Health-Related Quality of Life
IC  Intensive Care
ICC  Intraclass Correlations Coefficients 
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IMRT Intensity Modulated Radiation Therapy
IQR Interquartile Range
IRT  Item Response Theory
KPS Karnofsky Performance Status
LASSO  Least Absolute Shrinkage and Selection Operator
LENT/SOMA Late Effects Normal Tissue Subjective, Objective, Management, 
Analytic Scales
LUMC Leiden University Medical Center
MDADI MD Anderson Dysphagia Inventory
MeSH Medical Subject Headings
MIO Maximum Incisal Opening
ML Maximum Likelihood 
MMSE Mini Mental State Examination
MUMC  Maastricht University Medical Center
NHMRC National Health and Medical Research Council
NMES  Neuromuscular Electrical Stimulation
NMES-M Neuromuscular Electrical Stimulation at a Motor level
NMES-S  Neuromuscular Electrical Stimulation at a Sensory level
NOS Not Otherwise Specified 
NPV  Negative Predictive Value
OD Oropharyngeal Dysphagia
PAS Penetration Aspiration Scale 
PD Parkinson’s Disease 
PEG Percutaneous Endoscopic Gastrostomy
PPV Positive Predictive Value
PRISMA Preferred Reporting Items for Systematic Reviews and Meta 
Analyses
PSS-HN Performance Status Scale for Head & Neck cancer patients
QOL Quality of Life
ROC Receiver Operating Characteristic
RBHOMS Royal Brisbane Hospital Outcome Measure for Swallowing
ROM Range of Motion
RT  Radiotherapy
RTOG Radiation Therapy Oncology Group
SOAL  Swallowing Outcome after Laryngectomy
S-SECEL Swedish version of the Self-Evaluation of Communication 
Experiences after Laryngeal Cancer
SPS Swallowing Performance Status
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SSQ  Sydney Swallow Questionnaire
SUS Malmö Skane University Hospital Malmö
SWAL-QOL  Swallowing Qualitity of Life Questionnaire
TDC  Tissue/Dose Compensation
TOR-BSST  Toronto Bedside Swallowing Screening Test
TT  Traditional Therapy
UWQoL University of Washington Quality of Life Questionnaire
V  Voice or Speech 
VAS Visual Analogous Scale
VFS Videofluoroscopy
VHI Voice Handicap Index
VHI-10 Voice Handicap Index-10
VR-QoL Voice Related Quality of Life
V-VST  Volume-Viscosity Swallowing Test
WHO   World Health Organization
XQoL  Xerostomia Quality of Life Questionnaire
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Luctor et emergo. Het is volbracht. Volbracht omdat het een lange weg is geweest met 
kuilen, bergen en dalen. Met meestal licht aan het einde van de tunnel. Soms in het 
donker hebben anderen mij geholpen, hebben zij een stukje meegelopen of even licht 
gemaakt. Ondanks dat je een promotietraject voornamelijk alleen doet, wil ik een aantal 
mensen bedanken voor hun kennis, hulp, vriendschap, steun en liefde.
Geachte Professor Speyer, Beste Renée, Zonder jou zaten we hier niet. Jouw taak als 
een van de twee promotoren mag niet onderschat worden. Je kennis van de dysfagie, 
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te motiveren, relativeerde je het probleem en lukte het weer om door te gaan. 
Bedankt!
Geachte Professor Frijns, Beste Johan, Als mijn promotor wil ik je bedanken voor je 
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samenwerking.
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Je scherpe analytische blik en je hulp bij het concretiseren van oplossingen op 
verschillende momenten over verschillende onderwerpen is fantastisch en waardevol. 
We hebben gelachen en gehuild maar met jou ben ik steeds een stap verder gekomen. 
Dat je mijn paranimf wilde zijn betekent veel voor me. 
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Na afloop bent u
van harte welkom
op de receptie ter plaatse
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